A	O
conserved	O
tissue-specific	O
structure	O
at	O
a	O
human	B-DNA
T-cell	I-DNA
receptor	I-DNA
beta-chain	I-DNA
core	I-DNA
promoter	I-DNA
.	O

The	O
T-cell	B-DNA
receptor	I-DNA
(	I-DNA
TCR	I-DNA
)	I-DNA
beta-chain	I-DNA
promoters	I-DNA
have	O
been	O
characterized	O
as	O
nonstructured	B-DNA
basal	I-DNA
promoters	I-DNA
that	O
carry	O
a	O
single	O
conserved	O
ubiquitous	B-DNA
cyclic	I-DNA
AMP-responsive	I-DNA
element	I-DNA
.	O

Our	O
investigation	O
of	O
the	O
human	B-DNA
TCR	I-DNA
beta	I-DNA
gene	I-DNA
uncovers	O
a	O
surprisingly	O
complex	O
and	O
tissue-specific	O
structure	O
at	O
the	O
TCR	B-DNA
Vbeta	I-DNA
8.1	I-DNA
promoter	I-DNA
.	O

The	O
core	O
of	O
the	O
promoter	B-DNA
(	O
positions	B-DNA
-42	I-DNA
to	I-DNA
+11	I-DNA
)	O
is	O
recognized	O
by	O
the	O
lymphoid	B-protein
cell-specific	I-protein
transcription	I-protein
factors	I-protein
Ets-1	B-protein
,	O
LEF1	B-protein
,	O
and	O
AML1	B-protein
as	O
well	O
as	O
by	O
CREB/ATF-1	B-protein
,	O
as	O
is	O
demonstrated	O
in	O
gel	O
shift	O
and	O
footprinting	O
experiments	O
.	O

With	O
the	O
exception	O
of	O
LEF1	B-protein
,	O
these	O
factors	O
activate	O
transcription	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Binding	B-DNA
sites	I-DNA
at	O
the	O
core	O
region	O
show	O
little	O
conservation	O
with	O
consensus	B-DNA
sites	I-DNA
.	O

Nonetheless	O
,	O
CREB	B-protein
,	O
Ets-1	B-protein
,	O
and	O
AML1	B-protein
bind	O
and	O
activate	O
cooperatively	O
and	O
very	O
efficiently	O
through	O
the	O
nonconsensus	B-DNA
binding	I-DNA
sites	I-DNA
at	O
the	O
core	B-DNA
promoter	I-DNA
region	I-DNA
.	O

Moderate	O
ubiquitous	O
activation	O
is	O
further	O
induced	O
by	O
CREB/ATF	B-protein
and	I-protein
Sp1	I-protein
factors	I-protein
through	O
proximal	B-DNA
upstream	I-DNA
elements	I-DNA
.	O

The	O
tissue-specific	B-DNA
core	I-DNA
promoter	I-DNA
structure	I-DNA
is	O
apparently	O
conserved	O
in	O
other	O
T-cell-specifically	B-DNA
expressed	I-DNA
genes	I-DNA
such	O
as	O
the	O
CD4	B-DNA
gene	I-DNA
.	O

Our	O
observations	O
suggest	O
that	O
both	O
the	O
enhancer	B-DNA
and	O
the	O
promoter	B-DNA
have	O
a	O
complex	O
tissue-specific	O
structure	O
whose	O
functional	O
interplay	O
potentiates	O
T-cell-specific	O
transcription	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Aug.	NULL
1997	NULL
,	NULL
p.	NULL
4220-4229	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

8	NULL
A	NULL
Conserved	NULL
Tissue-Specific	NULL
Structure	NULL
at	NULL
a	NULL
Human	NULL
T-Cell	NULL
Receptor	NULL
B-Chain	NULL
Core	NULL
Promoter	NULL
JORN-PETER	NULL
HALLE	NULL
,	NULL
PHILIPP	NULL
HAUS-SEUFFERT	NULL
,	NULL
CLAUDIA	NULL
WOLTERING	NULL
,	NULL
GERTRAUD	NULL
STELZER	NULL
,	NULL
AND	NULL
MICHAEL	NULL
MEISTERERNST*	NULL
Laboratorium	NULL
fiir	NULL
Molekulare	NULL
Biologie-Genzentrum	NULL
der	NULL
Ludwig-Maximilians-Universitiit	NULL
Miinchen	NULL
,	NULL
D-81377	NULL
Munich	NULL
,	NULL
Germany	NULL
Received	NULL
24	NULL
January	NULL
1997/Returned	NULL
for	NULL
modification	NULL
6	NULL
March	NULL
1997/Accepted	NULL
17	NULL
April	NULL
1997	NULL
The	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
B-chain	NULL
promoters	NULL
have	NULL
been	NULL
characterized	NULL
as	NULL
nonstructured	NULL
basal	NULL
promoters	NULL
that	NULL
carry	NULL
a	NULL
single	NULL
conserved	NULL
ubiquitous	NULL
cyclic	NULL
AMP	NULL
element	NULL
.	NULL

Our	NULL
investigation	NULL
of	NULL
the	NULL
human	NULL
TCR	NULL
B	NULL
gene	NULL
uncovers	NULL
a	NULL
surprisingly	NULL
complex	NULL
and	NULL
tissue-specific	NULL
structure	NULL
at	NULL
the	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
.	NULL

The	NULL
core	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
positions	NULL
-42	NULL
to	NULL
+11	NULL
)	NULL
is	NULL
recognized	NULL
by	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
transcription	NULL
factors	NULL
Ets-1	NULL
,	NULL
LEF1	NULL
,	NULL
and	NULL
AML1	NULL
as	NULL
well	NULL
as	NULL
by	NULL
CREB/ATF-1	NULL
,	NULL
as	NULL
is	NULL
demonstrated	NULL
in	NULL
gel	NULL
shift	NULL
and	NULL
footprinting	NULL
experiments	NULL
.	NULL

With	NULL
the	NULL
exception	NULL
of	NULL
LEF1	NULL
,	NULL
these	NULL
factors	NULL
activate	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Binding	NULL
sites	NULL
at	NULL
the	NULL
core	NULL
region	NULL
show	NULL
little	NULL
conservation	NULL
with	NULL
consensus	NULL
sites	NULL
.	NULL

Nonetheless	NULL
,	NULL
CREB	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
AML1	NULL
bind	NULL
and	NULL
activate	NULL
cooperatively	NULL
and	NULL
very	NULL
efficiently	NULL
through	NULL
the	NULL
nonconsensus	NULL
binding	NULL
sites	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
.	NULL

Moderate	NULL
ubiquitous	NULL
activation	NULL
is	NULL
further	NULL
induced	NULL
by	NULL
CREB/ATF	NULL
and	NULL
Spl	NULL
factors	NULL
through	NULL
proximal	NULL
upstream	NULL
elements	NULL
.	NULL

The	NULL
tissue-specific	NULL
core	NULL
promoter	NULL
structure	NULL
is	NULL
apparently	NULL
conserved	NULL
in	NULL
other	NULL
T-cell-specifically	NULL
expressed	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
CD4	NULL
gene	NULL
.	NULL

Our	NULL
observations	NULL
suggest	NULL
that	NULL
both	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
have	NULL
a	NULL
complex	NULL
tissue-specific	NULL
structure	NULL
whose	NULL
functional	NULL
interplay	NULL
potentiates	NULL
T-cell-specific	NULL
transcription	NULL
.	NULL

T-cell-specific	NULL
expression	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-CD3	NULL
complex	NULL
and	NULL
the	NULL
CD4-CD8	NULL
coreceptors	NULL
depends	NULL
on	NULL
distal	NULL
enhancer	NULL
elements	NULL
(	NULL
8	NULL
,	NULL
18	NULL
,	NULL
22	NULL
,	NULL
29	NULL
,	NULL
31	NULL
,	NULL
38	NULL
,	NULL
46	NULL
,	NULL
64	NULL
,	NULL
78	NULL
,	NULL
80	NULL
)	NULL
,	NULL
which	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
B-cell-specific	NULL
regulation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
immunoglobulin	NULL
genes	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
enhancers	NULL
contain	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
ubiquitous	NULL
,	NULL
lymphoid	NULL
cell-	NULL
and	NULL
T-cell-specific	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
9	NULL
and	NULL
40	NULL
)	NULL
.	NULL

Many	NULL
T-cell-	NULL
and	NULL
lymphoid	NULL
cell-specific	NULL
factors	NULL
were	NULL
initially	NULL
identified	NULL
because	NULL
they	NULL
bind	NULL
to	NULL
functional	NULL
important	NULL
elements	NULL
of	NULL
the	NULL
TCR	NULL
en-hancers	NULL
.	NULL

Examples	NULL
are	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
high-mobility-group	NULL
(	NULL
HMG	NULL
)	NULL
box-containing	NULL
factors	NULL
TCF1	NULL
and	NULL
LEF1	NULL
(	NULL
T-cell	NULL
factor	NULL
1	NULL
and	NULL
lymphoid	NULL
enhancer	NULL
binding	NULL
factor	NULL
1	NULL
)	NULL
(	NULL
74	NULL
,	NULL
75	NULL
,	NULL
77	NULL
)	NULL
,	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
Ikaros	NULL
(	NULL
17	NULL
,	NULL
49	NULL
)	NULL
,	NULL
and	NULL
the	NULL
runt	NULL
domain	NULL
factor	NULL
PEBP2	NULL
«	NULL
(	NULL
polyomavirus	NULL
enhancer	NULL
binding	NULL
protein	NULL
2a	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
,	NULL
also	NULL
called	NULL
CBFa	NULL
(	NULL
core	NULL
binding	NULL
factor	NULL
a	NULL
)	NULL
,	NULL
is	NULL
the	NULL
murine	NULL
homolog	NULL
of	NULL
human	NULL
AML1	NULL
(	NULL
52	NULL
)	NULL
,	NULL
which	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
30	NULL
and	NULL
50	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
factors	NULL
Ets-1	NULL
,	NULL
Elf-1	NULL
,	NULL
and	NULL
GATA3	NULL
as	NULL
well	NULL
as	NULL
the	NULL
ubiquitous	NULL
CREB/ATF	NULL
family	NULL
bind	NULL
to	NULL
and	NULL
activate	NULL
the	NULL
TCR	NULL
enhancers	NULL
(	NULL
16	NULL
,	NULL
20	NULL
,	NULL
28	NULL
,	NULL
43	NULL
,	NULL
79	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
TCR	NULL
genes	NULL
is	NULL
dependent	NULL
on	NULL
distal	NULL
enhancers	NULL
(	NULL
22	NULL
,	NULL
38	NULL
,	NULL
40	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Like	NULL
other	NULL
tissue-specific	NULL
and	NULL
inducible	NULL
enhancer	NULL
elements	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
72	NULL
and	NULL
73	NULL
)	NULL
,	NULL
the	NULL
TCR	NULL
enhancers	NULL
assemble	NULL
the	NULL
transcription	NULL
factors	NULL
in	NULL
a	NULL
complex	NULL
multiprotein	NULL
structure	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
promoters	NULL
are	NULL
thought	NULL
to	NULL
contribute	NULL
little	NULL
to	NULL
tissue-specific	NULL
transcription	NULL
of	NULL
TCR	NULL
genes	NULL
(	NULL
40	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
sequence	NULL
comparisons	NULL
of	NULL
the	NULL
different	NULL
B-chain	NULL
promoters	NULL
revealed	NULL
only	NULL
one	NULL
conserved	NULL
element	NULL
(	NULL
1	NULL
,	NULL
59	NULL
,	NULL
69	NULL
)	NULL
.	NULL

It	NULL
resembles	NULL
a	NULL
cyclic	NULL
AMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
and	NULL
is	NULL
recognized	NULL
by	NULL
different	NULL
members	NULL
of	NULL
the	NULL
ubiquitous	NULL
CREB/ATF	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
2	NULL
,	NULL
16	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
a	NULL
murine	NULL
TCR	NULL
VB	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratorium	NULL
fiir	NULL
Molekulare	NULL
Biologie-Genzentrum	NULL
-	NULL
der	NULL
Ludwig-Maximilians-Universitat	NULL
Miinchen	NULL
,	NULL
Feodor-Lynen-Strasse	NULL
25	NULL
,	NULL
D-81377	NULL
Munich	NULL
,	NULL
Germany	NULL
.	NULL

Phone	NULL
:	NULL
49-89-74017203	NULL
.	NULL

Fax	NULL
:	NULL
49-89-74017448	NULL
.	NULL

E-mail	NULL
:	NULL
meister	NULL
@	NULL
lmb	NULL
.uni-muenchen.de	NULL
.	NULL

4220	NULL
promoter	NULL
suggested	NULL
that	NULL
the	NULL
CRE	NULL
is	NULL
the	NULL
only	NULL
promoter	NULL
element	NULL
that	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
(	NULL
2	NULL
)	NULL
.	NULL

With	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
CRE	NULL
,	NULL
TCR	NULL
promoters	NULL
seemed	NULL
to	NULL
be	NULL
un-related	NULL
,	NULL
based	NULL
on	NULL
previous	NULL
reports	NULL
(	NULL
1	NULL
,	NULL
59	NULL
,	NULL
69	NULL
)	NULL
.	NULL

On	NULL
certain	NULL
individual	NULL
promoters	NULL
,	NULL
functional	NULL
binding	NULL
of	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
Spl	NULL
(	NULL
37	NULL
)	NULL
and	NULL
TFII-I	NULL
(	NULL
42	NULL
)	NULL
could	NULL
be	NULL
demonstrated	NULL
.	NULL

In	NULL
other	NULL
cases	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
additional	NULL
lymphoid	NULL
cell-specific	NULL
factors	NULL
has	NULL
been	NULL
predicted	NULL
but	NULL
not	NULL
definitively	NULL
demonstrated	NULL
(	NULL
7	NULL
,	NULL
11	NULL
,	NULL
48	NULL
,	NULL
58	NULL
,	NULL
60	NULL
)	NULL
.	NULL

The	NULL
TCR	NULL
enhancers	NULL
can	NULL
function	NULL
through	NULL
a	NULL
variety	NULL
of	NULL
het-erologous	NULL
and	NULL
ubiquitous	NULL
promoters	NULL
(	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
appear	NULL
to	NULL
be	NULL
consistent	NULL
with	NULL
a	NULL
general	NULL
role	NULL
of	NULL
promoters	NULL
that	NULL
assemble	NULL
the	NULL
basal	NULL
machinery	NULL
,	NULL
being	NULL
rather	NULL
nonstructured	NULL
and	NULL
neither	NULL
contributing	NULL
substantially	NULL
to	NULL
tissue	NULL
specificity	NULL
nor	NULL
displaying	NULL
specificity	NULL
in	NULL
promoter-enhancer	NULL
interactions	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
descriptions	NULL
,	NULL
our	NULL
investigations	NULL
of	NULL
the	NULL
human	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
suggest	NULL
that	NULL
it	NULL
is	NULL
both	NULL
tissue-specifically	NULL
transcribed	NULL
and	NULL
highly	NULL
structured	NULL
.	NULL

We	NULL
identified	NULL
several	NULL
nonconsensus	NULL
elements	NULL
at	NULL
the	NULL
core	NULL
region	NULL
and	NULL
immediately	NULL
upstream	NULL
of	NULL
it	NULL
that	NULL
are	NULL
recognized	NULL
and	NULL
activated	NULL
by	NULL
both	NULL
ubiquitous	NULL
and	NULL
lymphoid	NULL
cell-specific	NULL
factors	NULL
.	NULL

Cooperativity	NULL
on	NULL
one	NULL
hand	NULL
between	NULL
factors	NULL
acting	NULL
through	NULL
the	NULL
core	NULL
promoter	NULL
regions	NULL
and	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
between	NULL
the	NULL
promoter	NULL
and	NULL
the	NULL
enhancer	NULL
establishes	NULL
a	NULL
mechanism	NULL
for	NULL
potentiation	NULL
of	NULL
tissue-specific	NULL
transcription	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Constructs	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
analyzed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Sequences	NULL
are	NULL
available	NULL
upon	NULL
request	NULL
.	NULL

TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
(	NULL
11	NULL
,	NULL
66	NULL
)	NULL
fragments	NULL
and	NULL
mutations	NULL
in	NULL
the	NULL
promoter	NULL
were	NULL
produced	NULL
by	NULL
PCR	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
XhoI	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
pGL2-Basic	NULL
(	NULL
Promega	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
human	NULL
TCR	NULL
B-chain	NULL
enhancer	NULL
(	NULL
positions	NULL
150	NULL
to	NULL
481	NULL
,	NULL
numbered	NULL
according	NULL
to	NULL
reference	NULL
22	NULL
)	NULL
was	NULL
produced	NULL
by	NULL
PCR	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

CD4	NULL
core	NULL
promoter	NULL
sequences	NULL
(	NULL
positions	NULL
-42	NULL
to	NULL
+20	NULL
)	NULL
(	NULL
62	NULL
)	NULL
were	NULL
synthesized	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
SmeI	NULL
and	NULL
Bg/II	NULL
sites	NULL
of	NULL
pGL2-Basic	NULL
.	NULL

The	NULL
vector	NULL
pGL2-promoter	NULL
(	NULL
Promega	NULL
)	NULL
contained	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
promoter	NULL
.	NULL

An	NULL
internal	NULL
control	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
the	NULL
B-galactosidase	NULL
cDNA	NULL
into	NULL
HindIII	NULL
and	NULL
BamHI	NULL
sites	NULL
of	NULL
pRe/CMV	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

For	NULL
production	NULL
of	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
probe	NULL
,	NULL
the	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
(	NULL
positions	NULL
-83	NULL
to	NULL
+11	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
Nof	NULL
]	NULL
site	NULL
of	NULL
pRe/CMV	NULL
.	NULL

The	NULL
cyto-	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
TISSUE-SPECIFIC	NULL
CORE	NULL
PROMOTER	NULL
-	NULL
4221	NULL
|	NULL
erst	NULL
___	NULL
|_	NULL
_tee	NULL
__|	NULL
[	NULL
amu	NULL
]	NULL
[	NULL
|___	NULL
cree	NULL
___|	NULL
[	NULL
amu1_	NULL
||	NULL
cree	NULL
|	NULL
(	NULL
|-a3	NULL
|-s3	NULL
|-42	NULL
|-28	NULL
-s	NULL
+1	NULL
+1	NULL
TTGGGGGTGGTGGCCCATTCAGTGATGTCACTGACAGATGCATTCTGTGGGGATAAAATGTCACAAAATTCATTTCTTTGCTCATGCTCACAGA	NULL
TeYeeT	NULL
WWCAAAGR	NULL
ACWTCCK	NULL
YYCANWYY	NULL
ceccee	NULL
TGACGTCA	NULL
TGYeeT	NULL
TGACGTCA	NULL
YCTTTGHW	NULL
WWCAAAGR	NULL
AML	NULL
__	NULL
LEF	NULL
sP1	NULL
cre	NULL
AML	NULL
_	NULL
CRE	NULL
_	NULL
ETS	NULL
LEF	NULL
INR	NULL
LEF	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Summary	NULL
of	NULL
structural	NULL
information	NULL
of	NULL
the	NULL
human	NULL
VB	NULL
8.1	NULL
promoter	NULL
,	NULL
as	NULL
deduced	NULL
from	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
defined	NULL
regulatory	NULL
factors	NULL
as	NULL
evidenced	NULL
by	NULL
footprinting	NULL
and	NULL
gel	NULL
shift	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
4D	NULL
,	NULL
and	NULL
5A	NULL
)	NULL
are	NULL
marked	NULL
by	NULL
boxes	NULL
.	NULL

Consensus	NULL
sequences	NULL
of	NULL
regulatory	NULL
elements	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
9	NULL
)	NULL
and	NULL
the	NULL
initiator	NULL
(	NULL
INR	NULL
)	NULL
(	NULL
33	NULL
)	NULL
are	NULL
indicated	NULL
below	NULL
the	NULL
corresponding	NULL
sites	NULL
.	NULL

Major	NULL
(	NULL
+1	NULL
)	NULL
and	NULL
minor	NULL
(	NULL
+7	NULL
,	NULL
+9	NULL
,	NULL
and	NULL
-12	NULL
)	NULL
transcription	NULL
start	NULL
sites	NULL
as	NULL
seen	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

megalovirus	NULL
(	NULL
CMV	NULL
)	NULL
and	NULL
TCR	NULL
VB	NULL
promoters	NULL
have	NULL
the	NULL
same	NULL
orientation	NULL
in	NULL
this	NULL
construct	NULL
.	NULL

An	NULL
antisense	NULL
transcript	NULL
of	NULL
both	NULL
promoters	NULL
was	NULL
generated	NULL
with	NULL
Sp6	NULL
polymerase	NULL
.	NULL

Reporter	NULL
gene	NULL
assay	NULL
.	NULL

Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
cultivated	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
10	NULL
and	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
PAN	NULL
Systems	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
at	NULL
densities	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
to	NULL
8	NULL
X	NULL
10°	NULL
(	NULL
Jurkat	NULL
)	NULL
or	NULL
2	NULL
X	NULL
10°	NULL
to	NULL
3	NULL
X	NULL
10°	NULL
(	NULL
HeLa	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

In	NULL
standard	NULL
reactions	NULL
,	NULL
approximately	NULL
1.6	NULL
X	NULL
10	NULL
``	NULL
Jurkat	NULL
and	NULL
8	NULL
X	NULL
10°	NULL
HeLa	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
luciferase	NULL
reporter	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
CMV-B-galactosidase	NULL
expression	NULL
plasmids	NULL
in	NULL
400	NULL
pl	NULL
of	NULL
RPMI	NULL
medium	NULL
lacking	NULL
serum	NULL
.	NULL

After	NULL
20	NULL
min	NULL
,	NULL
cells	NULL
were	NULL
electroporated	NULL
in	NULL
0.4-cm	NULL
cuvettes	NULL
at	NULL
960	NULL
mF	NULL
and	NULL
250	NULL
V	NULL
(	NULL
Gene	NULL
Pulser	NULL
;	NULL
Bio-Rad	NULL
)	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
20	NULL
min	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
reseeded	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
RPMI	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

For	NULL
maximum	NULL
TCR	NULL
B-gene	NULL
activity	NULL
(	NULL
56	NULL
)	NULL
,	NULL
10	NULL
ng	NULL
of	NULL
phorbol-12-myristate	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
was	NULL
added	NULL
4	NULL
h	NULL
after	NULL
electro-poration	NULL
.	NULL

At	NULL
36	NULL
to	NULL
40	NULL
h	NULL
after	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
150	NULL
pl	NULL
of	NULL
luciferase	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Supernatants	NULL
were	NULL
clarified	NULL
by	NULL
centrif-ugation	NULL
(	NULL
2	NULL
min	NULL
,	NULL
14,000	NULL
rpm	NULL
)	NULL
;	NULL
40	NULL
pl	NULL
was	NULL
mixed	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
luciferase	NULL
assay	NULL
solution	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
analyzed	NULL
in	NULL
a	NULL
Topcounter	NULL
(	NULL
Canberra-Packard	NULL
)	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
incubating	NULL
30	NULL
pl	NULL
of	NULL
the	NULL
supernatant	NULL
with	NULL
270	NULL
pl	NULL
of	NULL
B-galactosidase	NULL
assay	NULL
solution	NULL
(	NULL
63	NULL
)	NULL
and	NULL
measurement	NULL
of	NULL
optical	NULL
density	NULL
at	NULL
420	NULL
nm	NULL
.	NULL

Luciferase	NULL
units	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
values	NULL
except	NULL
when	NULL
Sp1	NULL
expression	NULL
vectors	NULL
were	NULL
cotransfected	NULL
,	NULL
which	NULL
significantly	NULL
stimulated	NULL
the	NULL
CMV	NULL
promoter	NULL
;	NULL
in	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
the	NULL
luciferase	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
total	NULL
protein	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

All	NULL
values	NULL
were	NULL
corrected	NULL
by	NULL
subtracting	NULL
background	NULL
activities	NULL
of	NULL
a	NULL
vector	NULL
lacking	NULL
the	NULL
promoter	NULL
.	NULL

Data	NULL
in	NULL
the	NULL
figures	NULL
are	NULL
the	NULL
means	NULL
of	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
+	NULL
standard	NULL
errors	NULL
of	NULL
means	NULL
.	NULL

When	NULL
expression	NULL
plasmids	NULL
were	NULL
present	NULL
in	NULL
cotransfection	NULL
studies	NULL
,	NULL
total	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
with	NULL
the	NULL
corresponding	NULL
empty	NULL
expression	NULL
vectors	NULL
.	NULL

RNase	NULL
protection	NULL
assays	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
of	NULL
DNA	NULL
plasmids	NULL
by	NULL
using	NULL
Qiagen	NULL
direct	NULL
mRNA	NULL
mini	NULL
kits	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
a	NULL
``	NULL
P-labeled	NULL
probe	NULL
complementary	NULL
to	NULL
the	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
luciferase	NULL
and	NULL
CMV-B-galactosidase	NULL
reporters	NULL
.	NULL

RNase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
63	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
.	NULL

Preparation	NULL
and	NULL
purification	NULL
of	NULL
recombinant	NULL
or	NULL
native	NULL
general	NULL
transcription	NULL
factors	NULL
,	NULL
TFIIA	NULL
,	NULL
TFIIB	NULL
,	NULL
TFIID	NULL
,	NULL
TFIE	NULL
,	NULL
TFHF	NULL
,	NULL
TFIIH	NULL
,	NULL
and	NULL
RNA	NULL
polymerase	NULL
II	NULL
,	NULL
and	NULL
the	NULL
conditions	NULL
used	NULL
for	NULL
the	NULL
transcription	NULL
reactions	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
,	NULL
47	NULL
,	NULL
70	NULL
)	NULL
.	NULL

Transcriptions	NULL
were	NULL
conducted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
M	NULL
all	NULL
four	NULL
nucleotides	NULL
,	NULL
and	NULL
transcripts	NULL
were	NULL
analyzed	NULL
by	NULL
primer	NULL
extension	NULL
with	NULL
an	NULL
end-labeled	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
28	NULL
bp	NULL
downstream	NULL
of	NULL
the	NULL
promoter	NULL
cloning	NULL
site	NULL
with	NULL
sequence	NULL
CTTTATGTITTTGGCGTCTTCCA	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Expression	NULL
and	NULL
purification	NULL
of	NULL
activator	NULL
proteins	NULL
.	NULL

All	NULL
recombinant	NULL
proteins	NULL
were	NULL
purified	NULL
from	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
.	NULL

An	NULL
Ncol-BamHI	NULL
fragment	NULL
of	NULL
the	NULL
CREB	NULL
cDNA	NULL
(	NULL
21	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
pET11d	NULL
.	NULL

Recombinant	NULL
CREB	NULL
encom-prising	NULL
amino	NULL
acids	NULL
3	NULL
to	NULL
341	NULL
was	NULL
enriched	NULL
from	NULL
£	NULL
.	NULL

coli	NULL
extracts	NULL
by	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
(	NULL
40	NULL
%	NULL
)	NULL
and	NULL
subsequently	NULL
heat	NULL
treated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
55°C	NULL
.	NULL

Full-length	NULL
Ets-1	NULL
was	NULL
expressed	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-Ets-1	NULL
(	NULL
20	NULL
)	NULL
was	NULL
purified	NULL
on	NULL
glutathione	NULL
columns	NULL
by	NULL
standard	NULL
methods	NULL
.	NULL

An	NULL
Ncol-HindIII	NULL
fragment	NULL
of	NULL
AML1	NULL
cDNA	NULL
(	NULL
52	NULL
,	NULL
20	NULL
)	NULL
was	NULL
cloned	NULL
in	NULL
pET28b	NULL
(	NULL
Novagen	NULL
)	NULL
,	NULL
and	NULL
the	NULL
carboxy-terminal	NULL
His-tagged	NULL
protein	NULL
was	NULL
purified	NULL
on	NULL
Ni-nitrilotriacetic	NULL
acid	NULL
columns	NULL
(	NULL
Qiagen	NULL
)	NULL
.	NULL

The	NULL
human	NULL
LEF1	NULL
cDNA	NULL
(	NULL
77	NULL
)	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
a	NULL
primer	NULL
generating	NULL
an	NULL
amino-terminal	NULL
Ndel	NULL
site	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Nde	NULL
!	NULL

site	NULL
of	NULL
pET11d	NULL
.	NULL

LEF1	NULL
carrying	NULL
an	NULL
amino-terminal	NULL
His	NULL
tag	NULL
was	NULL
purified	NULL
on	NULL
Ni-nitrilotriacetic	NULL
acid	NULL
columns	NULL
.	NULL

Footprints	NULL
and	NULL
EMSA	NULL
.	NULL

The	NULL
footprints	NULL
and	NULL
the	NULL
electromobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
performed	NULL
on	NULL
purified	NULL
PCR	NULL
fragments	NULL
of	NULL
the	NULL
promoter	NULL
produced	NULL
with	NULL
one	NULL
labeled	NULL
primer	NULL
.	NULL

A	NULL
labeled	NULL
coding	NULL
strand	NULL
was	NULL
used	NULL
except	NULL
in	NULL
the	NULL
CREB	NULL
footprint	NULL
,	NULL
in	NULL
which	NULL
the	NULL
noncoding	NULL
strand	NULL
was	NULL
labeled	NULL
.	NULL

Reaction	NULL
mixtures	NULL
included	NULL
40	NULL
fmol	NULL
of	NULL
the	NULL
DNA	NULL
fragment	NULL
,	NULL
1	NULL
g	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
the	NULL
amounts	NULL
of	NULL
proteins	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
25	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
8.2	NULL
)	NULL
-10	NULL
%	NULL
glycerol-4	NULL
mM	NULL
MgCl	NULL
,	NULL
-65	NULL
mM	NULL
KCI-5	NULL
mM	NULL
dithiothreitol-0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluo-ride-500	NULL
ng	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
pwl-0.002	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
25°C	NULL
.	NULL

In	NULL
EMSAs	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
directly	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
50:1	NULL
acrylamide	NULL
to	NULL
bisacrylamide	NULL
)	NULL
in	NULL
30	NULL
mM	NULL
Tris-borate	NULL
buffer	NULL
(	NULL
pH	NULL
8.2	NULL
)	NULL
and	NULL
run	NULL
at	NULL
5	NULL
V/cm	NULL
.	NULL

In	NULL
footprinting	NULL
experiments	NULL
,	NULL
DNase	NULL
I	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
was	NULL
added	NULL
in	NULL
amounts	NULL
and	NULL
for	NULL
periods	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
,	NULL
purified	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
denaturing	NULL
8	NULL
%	NULL
(	NULL
19:1	NULL
)	NULL
acrylamide-bisacrylamide	NULL
gels	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
.	NULL

RESULTS	NULL
Structure	NULL
and	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
understand	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
the	NULL
TCR	NULL
B	NULL
gene	NULL
,	NULL
we	NULL
have	NULL
reinvestigated	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
human	NULL
VB	NULL
8.1	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
utilized	NULL
in	NULL
the	NULL
recombined	NULL
TCR	NULL
B-chain	NULL
gene	NULL
locus	NULL
in	NULL
the	NULL
human	NULL
CD4*	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
was	NULL
initially	NULL
defined	NULL
with	NULL
deletion	NULL
constructs	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Promoter	NULL
activity	NULL
resided	NULL
within	NULL
an	NULL
approximately	NULL
94-bp	NULL
fragment	NULL
spanning	NULL
positions	NULL
-83	NULL
to	NULL
+11	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Constructs	NULL
comprising	NULL
positions	NULL
-42	NULL
to	NULL
+11	NULL
mediated	NULL
approximately	NULL
50	NULL
%	NULL
of	NULL
the	NULL
overall	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
and	NULL
were	NULL
sufficient	NULL
to	NULL
initiate	NULL
transcription	NULL
from	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
RNase	NULL
protection	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
;	NULL
compare	NULL
-42/+11	NULL
with	NULL
-83/+11	NULL
)	NULL
.	NULL

This	NULL
region	NULL
(	NULL
positions	NULL
-42	NULL
to	NULL
+11	NULL
)	NULL
is	NULL
subsequently	NULL
termed	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

Utilizing	NULL
the	NULL
deletion	NULL
constructs	NULL
,	NULL
we	NULL
then	NULL
investigated	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
core	NULL
and	NULL
upstream	NULL
promoter	NULL
regions	NULL
by	NULL
comparing	NULL
their	NULL
activities	NULL
in	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
VB	NULL
promoter	NULL
is	NULL
active	NULL
in	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
although	NULL
lower	NULL
luciferase	NULL
units	NULL
were	NULL
measured	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
points	NULL
to	NULL
the	NULL
functions	NULL
of	NULL
both	NULL
ubiquitous	NULL
and	NULL
lymphoid	NULL
cell-specific	NULL
factors	NULL
.	NULL

Preferential	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
suggested	NULL
by	NULL
normalization	NULL
of	NULL
luciferase	NULL
units	NULL
to	NULL
either	NULL
cotransfected	NULL
CMV	NULL
promoter/enhancer-driven	NULL
B-galactosidase	NULL
activities	NULL
or	NULL
activities	NULL
of	NULL
the	NULL
ubiquitously	NULL
transcribed	NULL
SV40	NULL
promoter	NULL
.	NULL

When	NULL
the	NULL
SV40	NULL
promoter	NULL
is	NULL
used	NULL
as	NULL
a	NULL
standard	NULL
,	NULL
the	NULL
promoter	NULL
is	NULL
about	NULL
three	NULL
times	NULL
more	NULL
active	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Normalization	NULL
to	NULL
a	NULL
CMV	NULL
pro-moter-driven	NULL
-galactosidase	NULL
gene	NULL
yielded	NULL
levels	NULL
sixfold	NULL
above	NULL
the	NULL
corresponding	NULL
activities	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Lymphoid	NULL
cell	NULL
specificity	NULL
resided	NULL
entirely	NULL
within	NULL
positions	NULL
-42	NULL
to	NULL
+11	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
core	NULL
promoter	NULL
could	NULL
be	NULL
further	NULL
subdivided	NULL
in	NULL
at	NULL
least	NULL
two	NULL
lymphoid	NULL
cell-specific	NULL
subregions	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
region	NULL
from	NULL
-42	NULL
to	NULL
-29	NULL
further	NULL
reduced	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
but	NULL
not	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Low	NULL
but	NULL
reproducible	NULL
activity	NULL
was	NULL
measured	NULL
solely	NULL
in	NULL
Jurkat	NULL
cells	NULL
with	NULL
a	NULL
minimal	NULL
promoter	NULL
construct	NULL
that	NULL
included	NULL
sequences	NULL
surrounding	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
(	NULL
positions	NULL
-8	NULL
to	NULL
+11	NULL
)	NULL
.	NULL

A	NULL
third	NULL
tissue-specific	NULL
element	NULL
,	NULL
with	NULL
weak	NULL
activity	NULL
,	NULL
is	NULL
located	NULL
between	NULL
positions	NULL
-28	NULL
and	NULL
-10	NULL
,	NULL
as	NULL
will	NULL
be	NULL
demonstrated	NULL
below	NULL
.	NULL

T-cell-specific	NULL
activity	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
(	NULL
62	NULL
)	NULL
,	NULL
which	NULL
served	NULL
here	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

4222	NULL
HALLE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
Promoter	NULL
Activity	NULL
0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
0.8	NULL
1.0	NULL
-797/+26	NULL
-83/+11	NULL
~42/+11	NULL
TCR	NULL
VB	NULL
8.1	NULL
-28/+11	NULL
-8/+11	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

-42/	NULL
+11	NULL
1	NULL
.	NULL

-83/	NULL
+11	NULL
RT	NULL
-	NULL
»	NULL
1.2	NULL
TCR	NULL
-	NULL
»	NULL
CMV-RT	NULL
-	NULL
»	NULL
RT	NULL
'	NULL
-	NULL
»	NULL
_	NULL
--	NULL
<	NULL
a-220	NULL
TCR	NULL
-	NULL
»	NULL
h	NULL
«	NULL
<	NULL
-	NULL
190	NULL
cuvy	NULL
-	NULL
@	NULL
0	NULL
I-	NULL
2	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

The	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
is	NULL
more	NULL
active	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Deletion	NULL
constructs	NULL
of	NULL
the	NULL
VB	NULL
8.1	NULL
promoter	NULL
were	NULL
analyzed	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
Jurkat	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
and	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
.	NULL

Positions	NULL
included	NULL
in	NULL
constructs	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
are	NULL
indicated	NULL
.	NULL

CMV-B-galactosidase	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
within	NULL
one	NULL
cell	NULL
type	NULL
,	NULL
and	NULL
the	NULL
SV40	NULL
promoter	NULL
was	NULL
used	NULL
as	NULL
a	NULL
standard	NULL
to	NULL
normalize	NULL
activities	NULL
in	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
CD4	NULL
promoter	NULL
(	NULL
62	NULL
)	NULL
construct	NULL
comprised	NULL
core	NULL
promoter	NULL
sequences	NULL
from	NULL
-42	NULL
to	NULL
+20	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
TCR	NULL
VB	NULL
8.1	NULL
mRNA	NULL
in	NULL
vivo	NULL
by	NULL
RNase	NULL
protection	NULL
.	NULL

RNA	NULL
generated	NULL
by	NULL
transfected	NULL
core	NULL
(	NULL
-42/+11	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
full-length	NULL
promoters	NULL
(	NULL
-83/+11	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
analyzed	NULL
.	NULL

Protected	NULL
fragments	NULL
originating	NULL
from	NULL
VB	NULL
promoters	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
cotransfected	NULL
CMV-B-galactosidase	NULL
(	NULL
CMV	NULL
)	NULL
,	NULL
read-through	NULL
transcripts	NULL
of	NULL
full-length	NULL
(	NULL
RT	NULL
)	NULL
,	NULL
core	NULL
VB	NULL
(	NULL
positions	NULL
-42	NULL
to	NULL
+11	NULL
)	NULL
(	NULL
RT	NULL
``	NULL
)	NULL
,	NULL
and	NULL
CMV	NULL
(	NULL
CMV-RT	NULL
)	NULL
promoters	NULL
and	NULL
the	NULL
positions	NULL
of	NULL
RNA	NULL
size	NULL
markers	NULL
(	NULL
sizes	NULL
in	NULL
base	NULL
pairs	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
protected	NULL
transcripts	NULL
of	NULL
the	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
were	NULL
approximately	NULL
200	NULL
bp	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
calculated	NULL
198	NULL
bp	NULL
for	NULL
a	NULL
transcript	NULL
starting	NULL
from	NULL
position	NULL
+1	NULL
.	NULL

Proximal	NULL
upstream	NULL
regions	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
ubiquitous	NULL
factors	NULL
.	NULL

The	NULL
CRE	NULL
conserved	NULL
in	NULL
the	NULL
TCR	NULL
VB	NULL
promoters	NULL
is	NULL
located	NULL
between	NULL
positions	NULL
-53	NULL
and	NULL
-60	NULL
at	NULL
the	NULL
VB	NULL
8.1	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
conservation	NULL
of	NULL
the	NULL
CRE	NULL
,	NULL
it	NULL
had	NULL
very	NULL
little	NULL
effect	NULL
on	NULL
promoter	NULL
activity	NULL
,	NULL
as	NULL
concluded	NULL
from	NULL
comparisons	NULL
of	NULL
the	NULL
-69/+11	NULL
and	NULL
-42/+11	NULL
deletion	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
various	NULL
point	NULL
mutations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
upstream	NULL
region	NULL
,	NULL
which	NULL
was	NULL
seen	NULL
in	NULL
both	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
was	NULL
entirely	NULL
mediated	NULL
through	NULL
an	NULL
element	NULL
further	NULL
upstream	NULL
(	NULL
positions	NULL
-83	NULL
to	NULL
-70	NULL
)	NULL
which	NULL
resembled	NULL
an	NULL
Spl	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Similar	NULL
GT	NULL
boxes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
have	NULL
Promoter	NULL
Activity	NULL
Spt	NULL
0	NULL
1	NULL
2	NULL
I	NULL
1	NULL
m=	NULL
[	NULL
spi	NULL
}	NULL
{	NULL
cre	NULL
[	NULL
ng	NULL
]	NULL
#	NULL
[	NULL
____-3	NULL
}	NULL
CRE	NULL
[	NULL
NE	NULL
|	NULL
i	NULL
+	NULL
[	NULL
]	NULL
+	NULL
n.d	NULL
.	NULL

FIG	NULL
.	NULL

3	NULL
.	NULL

Sp1	NULL
but	NULL
not	NULL
CREB	NULL
activates	NULL
through	NULL
upstream	NULL
regulatory	NULL
sequences	NULL
.	NULL

Deletion	NULL
constructs	NULL
comprising	NULL
positions	NULL
indicated	NULL
were	NULL
analyzed	NULL
in	NULL
Jurkat	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
cotransfected	NULL
Sp1	NULL
expression	NULL
vector	NULL
(	NULL
CMV-hSp1	NULL
)	NULL
(	NULL
25	NULL
)	NULL
if	NULL
indicated	NULL
.	NULL

The	NULL
promoter	NULL
was	NULL
in	NULL
cis	NULL
and	NULL
in	NULL
trans	NULL
dependent	NULL
on	NULL
Spl	NULL
and	NULL
the	NULL
Spl	NULL
element	NULL
,	NULL
respectively	NULL
,	NULL
but	NULL
not	NULL
on	NULL
the	NULL
CREB/ATF	NULL
site	NULL
(	NULL
CRE	NULL
)	NULL
.	NULL

Positions	NULL
relative	NULL
to	NULL
the	NULL
initiation	NULL
site	NULL
(	NULL
INR	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

n.d.	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

been	NULL
characterized	NULL
as	NULL
binding	NULL
sites	NULL
for	NULL
Spl	NULL
family	NULL
members	NULL
(	NULL
67	NULL
)	NULL
in	NULL
the	NULL
TCR	NULL
Va	NULL
(	NULL
37	NULL
)	NULL
and	NULL
uteroglobin	NULL
(	NULL
24	NULL
)	NULL
promoters	NULL
.	NULL

In	NULL
support	NULL
of	NULL
a	NULL
function	NULL
of	NULL
Spl	NULL
through	NULL
the	NULL
VB	NULL
promoter	NULL
,	NULL
overexpression	NULL
of	NULL
Spl	NULL
in	NULL
cotransfection	NULL
experiments	NULL
moderately	NULL
but	NULL
reproducibly	NULL
stimulated	NULL
the	NULL
promoter	NULL
,	NULL
and	NULL
this	NULL
activation	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
upstream	NULL
Sp1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
Sp1	NULL
may	NULL
contribute	NULL
to	NULL
ubiquitous	NULL
activity	NULL
of	NULL
the	NULL
VB	NULL
promoter	NULL
.	NULL

CREB	NULL
activates	NULL
the	NULL
promoter	NULL
through	NULL
a	NULL
cryptic	NULL
core	NULL
promoter	NULL
element	NULL
.	NULL

Cotransfection	NULL
of	NULL
CREB	NULL
or	NULL
ATF-1	NULL
expression	NULL
vectors	NULL
also	NULL
elevated	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
approximately	NULL
fivefold	NULL
stimulation	NULL
of	NULL
the	NULL
promoter	NULL
by	NULL
CREB	NULL
did	NULL
not	NULL
require	NULL
the	NULL
upstream	NULL
CRE	NULL
but	NULL
was	NULL
solely	NULL
dependent	NULL
on	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
comparisons	NULL
of	NULL
the	NULL
different	NULL
deletion	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
partially	NULL
conserved	NULL
CREB/ATF	NULL
binding	NULL
site	NULL
is	NULL
found	NULL
between	NULL
positions	NULL
-28	NULL
and	NULL
-21	NULL
.	NULL

The	NULL
core	NULL
CRE	NULL
contains	NULL
three	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
CREB	NULL
consensus	NULL
sequence	NULL
,	NULL
retaining	NULL
one	NULL
perfectly	NULL
conserved	NULL
half	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Lack	NULL
of	NULL
sequence	NULL
conservation	NULL
may	NULL
have	NULL
prevented	NULL
the	NULL
discovery	NULL
in	NULL
previous	NULL
investigations	NULL
of	NULL
the	NULL
core	NULL
CRE	NULL
,	NULL
which	NULL
is	NULL
therefore	NULL
termed	NULL
a	NULL
cryptic	NULL
CRE	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
core	NULL
promoter	NULL
by	NULL
CREB	NULL
and	NULL
ATF-1	NULL
was	NULL
activator	NULL
specific	NULL
.	NULL

AP1	NULL
,	NULL
which	NULL
recognizes	NULL
related	NULL
sequences	NULL
,	NULL
analyzed	NULL
through	NULL
cotransfection	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
expression	NULL
vectors	NULL
,	NULL
did	NULL
not	NULL
stimulate	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Activation	NULL
by	NULL
CREB	NULL
required	NULL
the	NULL
protein	NULL
kinase	NULL
A-inducible	NULL
domain	NULL
,	NULL
while	NULL
a	NULL
mutant	NULL
that	NULL
carries	NULL
a	NULL
serine-to-alanine	NULL
mutation	NULL
at	NULL
residue	NULL
133	NULL
(	NULL
CREB-M1	NULL
)	NULL
(	NULL
21	NULL
)	NULL
moderately	NULL
but	NULL
reproducibly	NULL
repressed	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
dominant	NULL
negative	NULL
effect	NULL
is	NULL
indicative	NULL
of	NULL
competition	NULL
of	NULL
the	NULL
overexpressed	NULL
mutant	NULL
with	NULL
endog-	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A	NULL
fold	NULL
activation	NULL
B	NULL
by	NULL
cotransfection	NULL
0	NULL
5	NULL
10	NULL
Fold	NULL
Stimulation	NULL
-83	NULL
-28	NULL
80	NULL
+11	NULL
i	NULL
7	NULL
i	NULL
ot	NULL
-5	NULL
CREB	NULL
_	NULL
6.6+/-0.9	NULL
cREs	NULL
Cal	NULL
CB	NULL
[	NULL
ing	NULL
]	NULL
Pp	NULL
)	NULL
=	NULL
--	NULL
CREB-M1	NULL
0.6	NULL
+/-0.2	NULL
-B	NULL
ATF	NULL
3.9	NULL
+/-	NULL
0.4	NULL
CREB	NULL
[	NULL
NC-	NULL
}	NULL
crse	NULL
|	NULL
)	NULL
)	NULL
AP1	NULL
0.9	NULL
+/-	NULL
0.1	NULL
-6	NULL
Ets-1	NULL
8.9	NULL
+/-	NULL
0.9	NULL
cRes	NULL
5	NULL
0.8	NULL
+/-	NULL
0.2	NULL
Ets-1	NULL
F-©	NULL
C	NULL
(	NULL
|/	NULL
&	NULL
p	NULL
&	NULL
8	NULL
5	NULL
C	NULL
ks	NULL
#	NULL
7	NULL
<	NULL
-10	NULL
--	NULL
&	NULL
*	NULL
$	NULL
8	NULL
6	NULL
@	NULL
-	NULL
a	NULL
~-\_~	NULL
US	NULL
#	NULL
L-	NULL
a	NULL
.	NULL

cre	NULL
!	NULL

e.	NULL
iB	NULL
__	NULL
we	NULL
jucgmed	NULL
m	NULL
ss	NULL
E	NULL
m	NULL
we	NULL
<	NULL
-	NULL
-12	NULL
ETS|	NULL
-30	NULL
-	NULL
»	NULL
.	NULL

,	NULL
®as	NULL
'	NULL
.	NULL

’	NULL
<	NULL
_.19	NULL
-20	NULL
Q	NULL
ie	NULL
|	NULL
cone	NULL
;	NULL
im	NULL
cre	NULL
S	NULL
I	NULL
i	NULL
:	NULL
l	NULL
»	NULL
&	NULL
--	NULL
-12	NULL
Mg	NULL
f	NULL
as	NULL
1	NULL
)	NULL
2	NULL
@	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

The	NULL
VB	NULL
promoter	NULL
strongly	NULL
responds	NULL
to	NULL
Ets-1	NULL
and	NULL
CREB/ATF-1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Core	NULL
promoter-dependent	NULL
activation	NULL
is	NULL
demonstrated	NULL
in	NULL
cotransfections	NULL
with	NULL
1	NULL
g	NULL
of	NULL
expression	NULL
vectors	NULL
encoding	NULL
CREB	NULL
(	NULL
pRSV-CREB	NULL
)	NULL
(	NULL
21	NULL
)	NULL
or	NULL
Ets-1	NULL
(	NULL
pEVRF-Ets-1	NULL
)	NULL
(	NULL
20	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Activation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
cryptic	NULL
CREB	NULL
(	NULL
CRE	NULL
)	NULL
and	NULL
Ets-1	NULL
(	NULL
ETS	NULL
)	NULL
binding	NULL
sites	NULL
located	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

INR	NULL
,	NULL
initiator	NULL
region	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activation	NULL
is	NULL
specific	NULL
for	NULL
CREB	NULL
,	NULL
ATF-1	NULL
(	NULL
ATF-1	NULL
eDNA	NULL
[	NULL
82	NULL
]	NULL
in	NULL
pRe/CMV	NULL
)	NULL
and	NULL
Ets-1	NULL
and	NULL
requires	NULL
the	NULL
CREB	NULL
activation	NULL
domain	NULL
.	NULL

CREB-Ser133Ala	NULL
carrying	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
protein	NULL
kinase	NULL
A	NULL
site	NULL
is	NULL
inactive	NULL
(	NULL
pRSV-CREB-M1	NULL
)	NULL
(	NULL
21	NULL
)	NULL
,	NULL
as	NULL
are	NULL
AP1	NULL
(	NULL
c-jun	NULL
and	NULL
c-fos	NULL
;	NULL
pRSV-cJ	NULL
and	NULL
pTK-FOS24	NULL
)	NULL
(	NULL
36	NULL
)	NULL
and	NULL
Elf-1	NULL
(	NULL
pCMV-Elf-1	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Expression	NULL
plasmids	NULL
(	NULL
1	NULL
mg	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
standard	NULL
concentrations	NULL
of	NULL
full-length	NULL
VB	NULL
-83/+11	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Analysis	NULL
of	NULL
pro-tein-DNA	NULL
interactions	NULL
in	NULL
DNase	NULL
I	NULL
footprints	NULL
(	NULL
10	NULL
ng	NULL
of	NULL
DNase	NULL
I	NULL
for	NULL
1	NULL
min	NULL
)	NULL
.	NULL

Recombinant	NULL
CREB	NULL
(	NULL
1.5	NULL
ug	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
binds	NULL
to	NULL
the	NULL
upstream	NULL
CREB/ATF	NULL
site	NULL
(	NULL
US	NULL
;	NULL
positions	NULL
-61	NULL
to	NULL
-54	NULL
)	NULL
and	NULL
the	NULL
cryptic	NULL
core	NULL
promoter	NULL
CREB/ATF	NULL
site	NULL
(	NULL
positions	NULL
-28	NULL
to	NULL
-21	NULL
)	NULL
,	NULL
the	NULL
latter	NULL
requiring	NULL
20-times-higher	NULL
CREB	NULL
concentrations	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
G+A	NULL
reaction	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
control	NULL
(	NULL
Co.	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Recombinant	NULL
GST-Ets-1	NULL
(	NULL
5	NULL
pg	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
protected	NULL
positions	NULL
-9	NULL
to	NULL
-32	NULL
in	NULL
DNase	NULL
footprinting	NULL
experiments	NULL
.	NULL

A	NULL
typical	NULL
hypersensitive	NULL
site	NULL
of	NULL
ETS	NULL
domain	NULL
proteins	NULL
(	NULL
23	NULL
)	NULL
is	NULL
visible	NULL
at	NULL
position	NULL
-19	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
control	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
G+A	NULL
reaction	NULL
.	NULL

enous	NULL
CREB/ATF-1	NULL
and	NULL
provides	NULL
indirect	NULL
evidence	NULL
that	NULL
CREB/ATF	NULL
proteins	NULL
function	NULL
through	NULL
the	NULL
core	NULL
promoter	NULL
at	NULL
physiological	NULL
concentrations	NULL
at	NULL
least	NULL
in	NULL
certain	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
function	NULL
of	NULL
CREB/ATF-1	NULL
transcription	NULL
factors	NULL
through	NULL
the	NULL
core	NULL
may	NULL
also	NULL
explain	NULL
the	NULL
activity	NULL
exhibited	NULL
by	NULL
the	NULL
region	NULL
spanning	NULL
positions	NULL
-28	NULL
to	NULL
-9	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
compare	NULL
-28/+11	NULL
and	NULL
-8/+11	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
CREB	NULL
to	NULL
the	NULL
promoter	NULL
was	NULL
also	NULL
demonstrated	NULL
in	NULL
in	NULL
vitro	NULL
footprinting	NULL
experiments	NULL
.	NULL

Recombinant	NULL
non-phosphorylated	NULL
CREB	NULL
expressed	NULL
in	NULL
and	NULL
purified	NULL
from	NULL
E.	NULL
coli	NULL
bound	NULL
to	NULL
both	NULL
the	NULL
upstream	NULL
and	NULL
the	NULL
low-affinity	NULL
core	NULL
CRE	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
although	NULL
the	NULL
conserved	NULL
upstream	NULL
CRE	NULL
was	NULL
protected	NULL
at	NULL
20-fold-lower	NULL
concentrations	NULL
.	NULL

These	NULL
data	NULL
not	NULL
only	NULL
suggest	NULL
a	NULL
function	NULL
of	NULL
CREB	NULL
through	NULL
the	NULL
VB	NULL
core	NULL
promoter	NULL
but	NULL
may	NULL
also	NULL
indicate	NULL
that	NULL
CREB	NULL
proteins	NULL
activate	NULL
more	NULL
efficiently	NULL
TISSUE-SPECIFIC	NULL
CORE	NULL
PROMOTER	NULL
-	NULL
4223	NULL
in	NULL
close	NULL
proximity	NULL
to	NULL
the	NULL
initiator	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Beyond	NULL
this	NULL
promoter	NULL
function	NULL
of	NULL
CREB	NULL
,	NULL
we	NULL
have	NULL
evidence	NULL
that	NULL
the	NULL
upstream	NULL
CRE	NULL
mediates	NULL
enhancer	NULL
function	NULL
,	NULL
which	NULL
may	NULL
provide	NULL
a	NULL
reasonable	NULL
explanation	NULL
for	NULL
its	NULL
conservation	NULL
in	NULL
the	NULL
different	NULL
VB	NULL
promoters	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
Ets-1	NULL
efficiently	NULL
activates	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

Our	NULL
initial	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
indicated	NULL
the	NULL
participation	NULL
of	NULL
additional	NULL
factors	NULL
at	NULL
core	NULL
promoter	NULL
regions	NULL
,	NULL
which	NULL
are	NULL
restricted	NULL
to	NULL
Jurkat	NULL
cells	NULL
.	NULL

Tissue-specific	NULL
core	NULL
promoter	NULL
activity	NULL
has	NULL
previously	NULL
been	NULL
described	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
Ets-1	NULL
protein	NULL
(	NULL
62	NULL
)	NULL
.	NULL

We	NULL
could	NULL
reproduce	NULL
this	NULL
finding	NULL
by	NULL
showing	NULL
(	NULL
i	NULL
)	NULL
that	NULL
the	NULL
CD4	NULL
promoter	NULL
is	NULL
inactive	NULL
in	NULL
HeLa	NULL
cells	NULL
but	NULL
active	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
that	NULL
overexpression	NULL
of	NULL
Ets-1	NULL
switches	NULL
the	NULL
promoter	NULL
on	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
Ets-1	NULL
on	NULL
VB	NULL
promoter	NULL
activity	NULL
,	NULL
although	NULL
homologies	NULL
to	NULL
Ets-1	NULL
consensus	NULL
sites	NULL
were	NULL
weak	NULL
.	NULL

However	NULL
,	NULL
Ets-1	NULL
could	NULL
very	NULL
efficiently	NULL
(	NULL
up	NULL
to	NULL
10-fold	NULL
)	NULL
activate	NULL
the	NULL
VB	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Activation	NULL
depended	NULL
on	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
which	NULL
contains	NULL
a	NULL
cryptic	NULL
Ets-1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
Ets-1	NULL
and	NULL
CREB	NULL
activate	NULL
transcription	NULL
very	NULL
efficiently	NULL
through	NULL
VB	NULL
core	NULL
promoter	NULL
regions	NULL
.	NULL

Ets-1	NULL
but	NULL
not	NULL
the	NULL
closely	NULL
related	NULL
factor	NULL
Elf-1	NULL
stimulated	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
Ets-1	NULL
binding	NULL
,	NULL
footprinting	NULL
experiments	NULL
were	NULL
conducted	NULL
with	NULL
recombinant	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Ets-1	NULL
interacted	NULL
specifically	NULL
with	NULL
the	NULL
core	NULL
region	NULL
exhibiting	NULL
the	NULL
characteristic	NULL
hypersensitive	NULL
site	NULL
within	NULL
the	NULL
protected	NULL
region	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Specific	NULL
binding	NULL
to	NULL
the	NULL
core	NULL
promoter	NULL
required	NULL
high	NULL
concentrations	NULL
of	NULL
expressed	NULL
Ets-1	NULL
.	NULL

This	NULL
may	NULL
be	NULL
partially	NULL
explained	NULL
by	NULL
the	NULL
known	NULL
low	NULL
affinity	NULL
of	NULL
Ets-1	NULL
for	NULL
its	NULL
own	NULL
recognition	NULL
site	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
factors	NULL
(	NULL
20	NULL
,	NULL
35	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
affinity	NULL
for	NULL
the	NULL
nonconserved	NULL
VB	NULL
core	NULL
promoter	NULL
element	NULL
between	NULL
positions	NULL
-17	NULL
and	NULL
-9	NULL
may	NULL
be	NULL
particularly	NULL
low	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
CREB	NULL
,	NULL
the	NULL
concentrations	NULL
of	NULL
Ets-1	NULL
apparently	NULL
do	NULL
not	NULL
suffice	NULL
to	NULL
significantly	NULL
activate	NULL
the	NULL
promoter	NULL
,	NULL
as	NULL
this	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
displayed	NULL
very	NULL
little	NULL
T-cell	NULL
specificity	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
Ets-1	NULL
concentrations	NULL
vary	NULL
during	NULL
differentiation	NULL
(	NULL
6	NULL
,	NULL
44	NULL
)	NULL
and	NULL
activation	NULL
(	NULL
5	NULL
,	NULL
55	NULL
)	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
leaving	NULL
open	NULL
the	NULL
possibility	NULL
that	NULL
Ets-1	NULL
activates	NULL
the	NULL
VB	NULL
promoter	NULL
at	NULL
some	NULL
point	NULL
during	NULL
development	NULL
.	NULL

In	NULL
any	NULL
event	NULL
,	NULL
we	NULL
note	NULL
a	NULL
potent	NULL
capacity	NULL
of	NULL
Ets-1	NULL
to	NULL
induce	NULL
the	NULL
promoter	NULL
through	NULL
core	NULL
promoter	NULL
elements	NULL
.	NULL

Conserved	NULL
AML1	NULL
and	NULL
LEF	NULL
sites	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
factors	NULL
other	NULL
than	NULL
Ets-1	NULL
must	NULL
be	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
core	NULL
promoter	NULL
effects	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
core	NULL
promoter	NULL
revealed	NULL
partially	NULL
conserved	NULL
binding	NULL
sites	NULL
for	NULL
AML1/PEBP2	NULL
«	NULL
/CBF	NULL
(	NULL
hereafter	NULL
termed	NULL
AML1	NULL
)	NULL
between	NULL
positions	NULL
-42	NULL
and	NULL
-29	NULL
and	NULL
for	NULL
TCF/LEF	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
initiation	NULL
site	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Footprinting	NULL
experiments	NULL
proved	NULL
that	NULL
recombinant	NULL
LEF1	NULL
and	NULL
AML1	NULL
proteins	NULL
could	NULL
indeed	NULL
bind	NULL
to	NULL
the	NULL
predicted	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Both	NULL
factors	NULL
also	NULL
protected	NULL
sites	NULL
in	NULL
the	NULL
upstream	NULL
promoter	NULL
region	NULL
against	NULL
DNase	NULL
I	NULL
digestion	NULL
.	NULL

These	NULL
recognition	NULL
sites	NULL
overlap	NULL
the	NULL
Sp1	NULL
and	NULL
CREB/ATF	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

Expression	NULL
of	NULL
AML1	NULL
in	NULL
Jurkat	NULL
cells	NULL
activated	NULL
the	NULL
promoter	NULL
up	NULL
to	NULL
threefold	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

This	NULL
activation	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
core	NULL
but	NULL
not	NULL
on	NULL
the	NULL
upstream	NULL
binding	NULL
site	NULL
,	NULL
which	NULL
overlaps	NULL
the	NULL
Sp1	NULL
site	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
AML	NULL
protein	NULL
functions	NULL
through	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
upstream	NULL
LEF1	NULL
binding	NULL
site	NULL
had	NULL
no	NULL
influence	NULL
on	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
two	NULL
core	NULL
promoter	NULL
LEF1	NULL
sites	NULL
reduced	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
these	NULL
sites	NULL
is	NULL
suggested	NULL
by	NULL
their	NULL
conservation	NULL
within	NULL
several	NULL
TCR	NULL
VB	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
CD4	NULL
core	NULL
promoter	NULL
is	NULL
remarkably	NULL
related	NULL
to	NULL
the	NULL
TCR	NULL
VRB	NULL
8.1	NULL
core	NULL
promoter	NULL
.	NULL

Homologies	NULL
at	NULL
4224	NULL
HALLE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
<	NULL
=	NULL
||	NULL
=	NULL
l	NULL
nt	NULL
=	NULL
5	NULL
26	NULL
)	NULL
&	NULL
o	NULL
a	NULL
‘	NULL
II	NULL
!	NULL

!	NULL

!	NULL

!	NULL

'gg	NULL
@	NULL
_	NULL
__	NULL
mil	NULL
litiad	NULL
=i	NULL
;	NULL
5._	NULL
;	NULL
DLEF	NULL
_	NULL
M	NULL
-26	NULL
-	NULL
»	NULL
l	NULL
Tk	NULL
=s	NULL
f	NULL
AML	NULL
-37	NULL
-	NULL
»	NULL
I	NULL
~54	NULL
-	NULL
»	NULL
-	NULL
-	NULL
Site	NULL
uite	NULL
cae	NULL
-	NULL
LEF	NULL
I	NULL
I	NULL
“	NULL
!	NULL

I1	NULL
HH	NULL
C-3I	NULL
Fold	NULL
Activation	NULL
by	NULL
AML1	NULL
cotransfection	NULL
“	NULL
al3	NULL
I2	NULL
“	NULL
2	NULL
's	NULL
fle	NULL
1	NULL
2	NULL
3	NULL
4	NULL
-4	NULL
I	NULL
[	NULL
spi	NULL
[	NULL
am	NULL
{	NULL
crelets	NULL
}	NULL
-INR	NULL
]	NULL
[	NULL
crefets	NULL
}	NULL
-ing	NULL
]	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

AML1	NULL
(	NULL
PEBP2	NULL
«	NULL
)	NULL
and	NULL
LEF	NULL
bind	NULL
to	NULL
and	NULL
AML1	NULL
activates	NULL
the	NULL
VB	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
of	NULL
recombinant	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
AML1	NULL
(	NULL
lane	NULL
2	NULL
,	NULL
40	NULL
ng	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
control	NULL
[	NULL
Co.	NULL
]	NULL
)	NULL
and	NULL
full-length	NULL
LEF1	NULL
(	NULL
lane	NULL
4	NULL
,	NULL
200	NULL
ng	NULL
)	NULL
was	NULL
analyzed	NULL
in	NULL
DNase	NULL
I	NULL
footprinting	NULL
experiments	NULL
(	NULL
10	NULL
ng	NULL
of	NULL
DNase	NULL
I	NULL
for	NULL
1	NULL
min	NULL
)	NULL
.	NULL

On	NULL
the	NULL
left	NULL
,	NULL
the	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
are	NULL
indicated	NULL
(	NULL
lane	NULL
1	NULL
,	NULL
G+A	NULL
reaction	NULL
)	NULL
.	NULL

AML1	NULL
protected	NULL
positions	NULL
-39	NULL
to	NULL
-29	NULL
and	NULL
less	NULL
efficiently	NULL
positions	NULL
-79	NULL
and	NULL
-70	NULL
,	NULL
and	NULL
LEF1	NULL
protected	NULL
positions	NULL
-69	NULL
to	NULL
-58	NULL
and	NULL
positions	NULL
-8	NULL
to	NULL
+5	NULL
,	NULL
as	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

On	NULL
the	NULL
other	NULL
DNA	NULL
strand	NULL
,	NULL
LEF1	NULL
protected	NULL
positions	NULL
-8	NULL
to	NULL
+11	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cotransfection	NULL
of	NULL
2	NULL
pg	NULL
of	NULL
pCG-PEBP2	NULL
«	NULL
(	NULL
20	NULL
)	NULL
,	NULL
comprising	NULL
amino	NULL
acids	NULL
35	NULL
to	NULL
501	NULL
of	NULL
AML1	NULL
(	NULL
52	NULL
)	NULL
,	NULL
activated	NULL
dependent	NULL
on	NULL
the	NULL
AML1	NULL
site	NULL
(	NULL
AML	NULL
)	NULL
located	NULL
between	NULL
positions	NULL
-42	NULL
and	NULL
-29	NULL
.	NULL

Activation	NULL
of	NULL
AML1	NULL
through	NULL
the	NULL
upstream	NULL
binding	NULL
site	NULL
,	NULL
which	NULL
was	NULL
found	NULL
in	NULL
in	NULL
vitro	NULL
footprinting	NULL
experiments	NULL
and	NULL
which	NULL
overlaps	NULL
with	NULL
the	NULL
Sp1	NULL
recognition	NULL
site	NULL
,	NULL
was	NULL
not	NULL
detectable	NULL
.	NULL

INR	NULL
,	NULL
initiator	NULL
region	NULL
.	NULL

the	NULL
CD4	NULL
promoter	NULL
include	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
and	NULL
the	NULL
Ets-1	NULL
,	NULL
AML1	NULL
,	NULL
and	NULL
both	NULL
putative	NULL
LEF1	NULL
binding	NULL
sites	NULL
but	NULL
not	NULL
the	NULL
core	NULL
CRE	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Absence	NULL
of	NULL
the	NULL
latter	NULL
provides	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
activity	NULL
of	NULL
the	NULL
CD4	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Transient	NULL
LEF1	NULL
expression	NULL
did	NULL
not	NULL
stimulate	NULL
the	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
we	NULL
did	NULL
not	NULL
yet	NULL
succeed	NULL
in	NULL
reconstituting	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
core	NULL
promoter	NULL
(	NULL
positions	NULL
-8	NULL
to	NULL
+11	NULL
)	NULL
in	NULL
HeLa	NULL
cells	NULL
Hence	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
involvement	NULL
of	NULL
other	NULL
activators	NULL
.	NULL

These	NULL
,	NULL
however	NULL
,	NULL
could	NULL
also	NULL
be	NULL
other	NULL
members	NULL
of	NULL
the	NULL
TCF/LEF	NULL
family	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
conserved	NULL
region	NULL
in	NULL
the	NULL
immediate	NULL
vicinity	NULL
of	NULL
the	NULL
initiator	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
it	NULL
might	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
general	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
VB	NULL
core	NULL
promoter	NULL
contains	NULL
two	NULL
basal	NULL
elements	NULL
,	NULL
a	NULL
residual	NULL
TATA	NULL
box	NULL
and	NULL
an	NULL
initiator	NULL
region	NULL
.	NULL

The	NULL
latter	NULL
closely	NULL
resembles	NULL
the	NULL
initiator	NULL
consensus	NULL
sequence	NULL
(	NULL
33	NULL
)	NULL
with	NULL
the	NULL
notable	NULL
exception	NULL
of	NULL
a	NULL
G	NULL
residue	NULL
at	NULL
position	NULL
+3	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Mutations	NULL
within	NULL
the	NULL
initiator	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Relative	NULL
Promoter	NULL
Activity	NULL
-69	NULL
~42	NULL
-8	NULL
+11	NULL
o	NULL
0.5	NULL
1	NULL
1.5	NULL
I	NULL
I	NULL
I	NULL
I	NULL
[	NULL
LeFJinR	NULL
]	NULL
XF	NULL
[	NULL
LeF	NULL
]	NULL
inR	NULL
JLEF	NULL
]	NULL
-83	NULL
LEF	NULL
[	NULL
LeFJing	NULL
[	NULL
LEF	NULL
]	NULL
|F	NULL
]	NULL
ing	NULL
[	NULL
LEF	NULL
]	NULL
[	NULL
LEF	NULL
]	NULL
NR	NULL
J	NULL
Of	NULL
]	NULL
w	NULL
[	NULL
Lee	NULL
]	NULL
Ip	NULL
@	NULL
[	NULL
LEF	NULL
]	NULL
UJ	NULL
O	NULL
WT	NULL
DS-MT	NULL
INR-CS	NULL
INR-MT	NULL
LEF	NULL
LEF	NULL
YCTTTGWW	NULL
WWCAAAGR	NULL
VR	NULL
8.1	NULL
.	NULL

TCTPPGCTCATGCTCACAGA	NULL
VB	NULL
8.2	NULL
tctttgctcatgttcacaga	NULL
VR	NULL
8.3	NULL
cctttgagcagggacagaga	NULL
VB	NULL
8.4	NULL
tctttgttcatgctcacaga	NULL
-21	NULL
VB	NULL
8.5	NULL
ttcttgctcattctcataag	NULL
a	NULL
91	NULL
a	NULL
vB	NULL
16	NULL
getttcctttttctcatact	NULL
VR	NULL
21.2	NULL
cctctgetcctgctcacagt	NULL
12	NULL
,	NULL
»	NULL
«	NULL
--	NULL
-	NULL
ap	NULL
VB	NULL
23	NULL
cttttgctcctcctcacegt	NULL
vB	NULL
26	NULL
totttgctactgcacatcag	NULL
+1=	NULL
>	NULL
~	NULL
as	NULL
as	NULL
+7	NULL
-	NULL
»	NULL
+9	NULL
-	NULL
#	NULL
ue	NULL
*	NULL
am	NULL
--	NULL
1	NULL
2	NULL
3	NULL
4	NULL
C	NULL
AML	NULL
ETS	NULL
LEF	NULL
INR	NULL
vR8.1	NULL
ATTC	NULL
ATAAAATGTCA	NULL
CAARMA	NULL
CTTTGC	NULL
ACA	NULL
CD4	NULL
AGGG	NULL
ABGAGCCTTGCCATCG	NULL
AAGCA	NULL
YCTTTGWW	NULL
TGYGGT	NULL
ACWTCCKGY	NULL
YYCANWYY	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

A	NULL
conserved	NULL
functional	NULL
TCF/LEF-like	NULL
element	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Mutations	NULL
within	NULL
both	NULL
core	NULL
promoter	NULL
LEF1	NULL
binding	NULL
sites	NULL
(	NULL
LEF	NULL
)	NULL
,	NULL
designed	NULL
to	NULL
not	NULL
change	NULL
the	NULL
partially	NULL
overlapping	NULL
upstream	NULL
CRE	NULL
and	NULL
the	NULL
initiator	NULL
(	NULL
INR	NULL
)	NULL
consensus	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
but	NULL
not	NULL
within	NULL
the	NULL
upstream	NULL
site	NULL
reduce	NULL
promoter	NULL
activity	NULL
.	NULL

Mutations	NULL
were	NULL
TTCAGTGA	NULL
to	NULL
TTCgaTGA	NULL
(	NULL
in	NULL
the	NULL
-69/+11	NULL
con-struct	NULL
)	NULL
,	NULL
TCTTTGCT	NULL
to	NULL
and	NULL
CTCACAGA	NULL
to	NULL
CTCeataA	NULL
in	NULL
the	NULL
three	NULL
putative	NULL
LEF	NULL
boxes	NULL
,	NULL
and	NULL
,	NULL
to	NULL
inactivate	NULL
the	NULL
initiator	NULL
,	NULL
CTCA	NULL
,	NULL
,	NULL
TGCT	NULL
to	NULL
gegA	NULL
,	NULL
i	NULL
TGCT	NULL
,	NULL
all	NULL
in	NULL
the	NULL
-83/+11	NULL
context	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
sequences	NULL
surrounding	NULL
the	NULL
initiator	NULL
are	NULL
conserved	NULL
in	NULL
different	NULL
TCR	NULL
VB	NULL
promoters	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
alignment	NULL
(	NULL
1	NULL
,	NULL
69	NULL
)	NULL
of	NULL
the	NULL
initiator	NULL
regions	NULL
and	NULL
comparison	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
LEFI	NULL
.	NULL

Homologies	NULL
to	NULL
the	NULL
consensus	NULL
sequences	NULL
are	NULL
in	NULL
boldface	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Several	NULL
regulatory	NULL
elements	NULL
are	NULL
conserved	NULL
between	NULL
the	NULL
TCR	NULL
VB	NULL
and	NULL
the	NULL
CD4	NULL
core	NULL
promoter	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
alignment	NULL
of	NULL
promoters	NULL
and	NULL
comparison	NULL
of	NULL
consensus	NULL
sequences	NULL
of	NULL
activator	NULL
recognition	NULL
sites	NULL
.	NULL

Homologies	NULL
to	NULL
the	NULL
consensus	NULL
sequences	NULL
are	NULL
shown	NULL
in	NULL
boldface	NULL
.	NULL

(	NULL
D	NULL
)	NULL
In	NULL
vitro	NULL
analysis	NULL
of	NULL
core	NULL
promoters	NULL
in	NULL
a	NULL
purified	NULL
transcription	NULL
system	NULL
.	NULL

The	NULL
wild-type	NULL
promoter	NULL
(	NULL
WT	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
the	NULL
downstream	NULL
LEF	NULL
]	NULL
mutation	NULL
(	NULL
DS-MT	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
a	NULL
conversion	NULL
of	NULL
the	NULL
initiator	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
(	NULL
CTCA	NULL
,	NULL
;	NULL
THCT	NULL
)	NULL
(	NULL
INR-CS	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
an	NULL
initiator	NULL
down-mutation	NULL
as	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
(	NULL
INR-MT	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
primer	NULL
extension	NULL
.	NULL

Positions	NULL
refer	NULL
to	NULL
the	NULL
major	NULL
in	NULL
vivo	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Transcription	NULL
start	NULL
sites	NULL
upstream	NULL
and	NULL
downstream	NULL
of	NULL
+1	NULL
are	NULL
observed	NULL
as	NULL
minor	NULL
transcription	NULL
start	NULL
sites	NULL
that	NULL
do	NULL
not	NULL
substantially	NULL
contribute	NULL
to	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
in	NULL
vitro	NULL
(	NULL
27	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
reference	NULL
11	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
due	NULL
to	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
at	NULL
positions	NULL
+1	NULL
to	NULL
+3	NULL
,	NULL
which	NULL
is	NULL
out	NULL
of	NULL
frame	NULL
with	NULL
the	NULL
luciferase	NULL
open	NULL
reading	NULL
frame	NULL
and	NULL
with	NULL
the	NULL
TCR	NULL
B	NULL
coding	NULL
region	NULL
in	NULL
the	NULL
native	NULL
context	NULL
transcripts	NULL
starting	NULL
from	NULL
upstream	NULL
sites	NULL
will	NULL
probably	NULL
not	NULL
contribute	NULL
to	NULL
protein	NULL
expression	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
consensus	NULL
sequence	NULL
strongly	NULL
reduced	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
initiator	NULL
but	NULL
not	NULL
the	NULL
TATA	NULL
box	NULL
is	NULL
important	NULL
for	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
basal	NULL
elements	NULL
alone	NULL
are	NULL
not	NULL
sufficient	NULL
to	NULL
confer	NULL
measurable	NULL
promoter	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

However	NULL
,	NULL
sequences	NULL
surrounding	NULL
the	NULL
initiator	NULL
might	NULL
also	NULL
affect	NULL
the	NULL
function	NULL
of	NULL
other	NULL
general	NULL
factors	NULL
such	NULL
as	NULL
TFIIE	NULL
(	NULL
32	NULL
)	NULL
.	NULL

We	NULL
have	NULL
investigated	NULL
this	NULL
issue	NULL
by	NULL
analyzing	NULL
core	NULL
promoter	NULL
constructs	NULL
in	NULL
a	NULL
purified	NULL
HeLa-derived	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
.	NULL

This	NULL
system	NULL
contains	NULL
a	NULL
complete	NULL
set	NULL
of	NULL
general	NULL
transcription	NULL
factors	NULL
but	NULL
is	NULL
devoid	NULL
of	NULL
regulatory	NULL
factors	NULL
.	NULL

Transcripts	NULL
started	NULL
from	NULL
several	NULL
sites	NULL
in	NULL
purified	NULL
systems	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

These	NULL
were	NULL
generated	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
inhibition	NULL
with	NULL
«	NULL
-amanitin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Upstream	NULL
start	NULL
sites	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
at	NULL
position	NULL
-12	NULL
,	NULL
probably	NULL
do	NULL
not	NULL
contribute	NULL
to	NULL
gene	NULL
activity	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
the	NULL
promoter	NULL
contains	NULL
an	NULL
ATG	NULL
start	NULL
codon	NULL
at	NULL
position	NULL
+1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
downstream	NULL
LEF1	NULL
site	NULL
barely	NULL
affected	NULL
transcription	NULL
from	NULL
the	NULL
major	NULL
start	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
,	NULL
though	NULL
they	NULL
led	NULL
to	NULL
qualitative	NULL
changes	NULL
at	NULL
the	NULL
minor	NULL
transcription	NULL
start	NULL
site	NULL
at	NULL
position	NULL
+9	NULL
.	NULL

Similarly	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
second	NULL
LEF1	NULL
,	NULL
the	NULL
AML	NULL
,	NULL
the	NULL
CREB	NULL
,	NULL
and	NULL
the	NULL
Ets	NULL
elements	NULL
did	NULL
not	NULL
affect	NULL
basal	NULL
promoter	NULL
activity	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
mutation	NULL
within	NULL
the	NULL
initiator	NULL
consensus	NULL
sequence	NULL
(	NULL
positions	NULL
-3	NULL
to	NULL
+1	NULL
from	NULL
CTCA	NULL
to	NULL
GGGA	NULL
)	NULL
abolished	NULL
starts	NULL
of	NULL
transcription	NULL
from	NULL
position	NULL
+1	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
an	NULL
initiator	NULL
consensus	NULL
sequence	NULL
,	NULL
by	NULL
changing	NULL
position	NULL
+3	NULL
from	NULL
G	NULL
to	NULL
T	NULL
,	NULL
did	NULL
not	NULL
influence	NULL
basal	NULL
transcription	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
mutations	NULL
in	NULL
the	NULL
LEF1	NULL
sites	NULL
indeed	NULL
impair	NULL
the	NULL
function	NULL
of	NULL
regulatory	NULL
but	NULL
not	NULL
of	NULL
general	NULL
factors	NULL
.	NULL

While	NULL
not	NULL
yet	NULL
identifying	NULL
unambiguously	NULL
the	NULL
specific	NULL
activators	NULL
acting	NULL
through	NULL
the	NULL
LEF1	NULL
binding	NULL
sites	NULL
,	NULL
our	NULL
data	NULL
provide	NULL
indications	NULL
for	NULL
a	NULL
T-cell-specific	NULL
core	NULL
promoter	NULL
structure	NULL
that	NULL
is	NULL
conserved	NULL
in	NULL
several	NULL
promoters	NULL
.	NULL

Cooperativity	NULL
in	NULL
binding	NULL
and	NULL
activation	NULL
of	NULL
core	NULL
promoters	NULL
.	NULL

The	NULL
complex	NULL
structure	NULL
of	NULL
the	NULL
TCR	NULL
VfB	NULL
8.1	NULL
promoter	NULL
is	NULL
remarkably	NULL
reminiscent	NULL
of	NULL
the	NULL
corresponding	NULL
enhancer	NULL
complexes	NULL
(	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
the	NULL
activators	NULL
which	NULL
are	NULL
shown	NULL
here	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
TCR	NULL
promoter	NULL
are	NULL
also	NULL
part	NULL
of	NULL
the	NULL
TCR	NULL
enhancer	NULL
complexes	NULL
.	NULL

The	NULL
arrangement	NULL
is	NULL
not	NULL
identical	NULL
but	NULL
in	NULL
some	NULL
situations	NULL
is	NULL
similar	NULL
.	NULL

For	NULL
example	NULL
,	NULL
ETS	NULL
elements	NULL
are	NULL
usually	NULL
located	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
AML1	NULL
recognition	NULL
sites	NULL
.	NULL

On	NULL
the	NULL
enhancers	NULL
,	NULL
these	NULL
transcription	NULL
factors	NULL
bind	NULL
cooperatively	NULL
and	NULL
activate	NULL
synergis-tically	NULL
(	NULL
20	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
could	NULL
show	NULL
that	NULL
Ets-1	NULL
binding	NULL
to	NULL
the	NULL
cryptic	NULL
core	NULL
sites	NULL
is	NULL
enhanced	NULL
,	NULL
if	NULL
CREB	NULL
binds	NULL
to	NULL
the	NULL
adjacent	NULL
core	NULL
CRE	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
;	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
Ets-CREB	NULL
complex	NULL
comigrated	NULL
with	NULL
the	NULL
Ets-1	NULL
complex	NULL
seen	NULL
at	NULL
higher	NULL
concentrations	NULL
(	NULL
compare	NULL
lane	NULL
3	NULL
with	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
CREB-Ets-1	NULL
complex	NULL
displayed	NULL
reduced	NULL
mobility	NULL
at	NULL
high	NULL
Ets-1	NULL
concentrations	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Ets-CREB	NULL
complexes	NULL
were	NULL
supershifted	NULL
with	NULL
antibodies	NULL
against	NULL
both	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
low	NULL
mobility	NULL
of	NULL
Ets-1	NULL
alone	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
two	NULL
Ets-1	NULL
molecules	NULL
at	NULL
higher	NULL
concentrations	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Cooperativity	NULL
in	NULL
binding	NULL
to	NULL
the	NULL
T-cell	NULL
enhancers	NULL
has	NULL
been	NULL
described	NULL
in	NULL
the	NULL
cases	NULL
of	NULL
AML1	NULL
and	NULL
Ets-1	NULL
(	NULL
20	NULL
,	NULL
79	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
could	NULL
also	NULL
observe	NULL
cooperative	NULL
binding	NULL
of	NULL
the	NULL
AML1	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
Ets-1	NULL
at	NULL
the	NULL
TCR	NULL
VRB	NULL
8.1	NULL
promoter	NULL
both	NULL
in	NULL
EMSAs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
in	NULL
footprinting	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

At	NULL
limiting	NULL
factor	NULL
concentrations	NULL
,	NULL
allowing	NULL
no	NULL
individual	NULL
footprints	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
Ets-1	NULL
and	NULL
AML1	NULL
produced	NULL
a	NULL
footprint	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
region	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
with	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
binding	NULL
of	NULL
CREB	NULL
to	NULL
the	NULL
core	NULL
promoter	NULL
assisted	NULL
Ets-1	NULL
binding	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

In	NULL
combination	NULL
,	NULL
the	NULL
three	NULL
factors	NULL
moderately	NULL
but	NULL
significantly	NULL
protected	NULL
the	NULL
core	NULL
promoter	NULL
more	NULL
efficiently	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

We	NULL
could	NULL
not	NULL
detect	NULL
cooperative	NULL
binding	NULL
of	NULL
CREB	NULL
and	NULL
the	NULL
AML1	NULL
DNA	NULL
binding	NULL
domain	NULL
in	NULL
footprinting	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
TISSUE-SPECIFIC	NULL
CORE	NULL
PROMOTER	NULL
-	NULL
4225	NULL
B	NULL
CREB	NULL
-	NULL
+	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+-Ets-1	NULL
-	NULL
-+	NULL
+	NULL
-	NULL
+	NULL
+-AML1	NULL
A	NULL
+1	NULL
-	NULL
»	NULL
CREB	NULL
|	NULL
-	NULL
-	NULL
-	NULL
$	NULL
$	NULL
¢	NULL
f	NULL
Ets	NULL
*	NULL
sETS	NULL
_	NULL
‘	NULL
_	NULL
‘	NULL
|	NULL
Co	NULL
-19	NULL
_	NULL
>	NULL
l	NULL
``	NULL
'	NULL
``	NULL
.	NULL
'	NULL

ﬂ	NULL
``	NULL
'	NULL
re	NULL
M	NULL
#	NULL
#	NULL
CREB	NULL
b*	NULL
ist	NULL
)	NULL
|4	NULL
we	NULL
’	NULL
§35§§__§	NULL
|amL1	NULL
~420	NULL
-	NULL
>	NULL
)	NULL
&	NULL
@	NULL
@	NULL
e	NULL
we	NULL
m	NULL
tr	NULL
tf	NULL
;	NULL
;	NULL
--	NULL
-¢-	NULL
bucd	NULL
£	NULL
.	NULL

l	NULL
«	NULL
w	NULL
ap	NULL
<	NULL
f	NULL
“	NULL
a	NULL
las	NULL
bat	NULL
'	NULL
so	NULL
set	NULL
%	NULL
||	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
«	NULL
*L.	NULL
pa	NULL
ones	NULL
+71	NULL
-	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Cooperative	NULL
binding	NULL
of	NULL
activators	NULL
to	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Gel	NULL
mobility	NULL
shift	NULL
experiments	NULL
using	NULL
a	NULL
core	NULL
promoter	NULL
oligonucleotide	NULL
comprising	NULL
positions	NULL
-42	NULL
to	NULL
+11	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
Ets-1	NULL
(	NULL
0	NULL
ng	NULL
[	NULL
lane	NULL
1	NULL
and	NULL
4	NULL
]	NULL
,	NULL
200	NULL
ng	NULL
[	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
]	NULL
,	NULL
and	NULL
1	NULL
g	NULL
[	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
]	NULL
)	NULL
were	NULL
analyzed	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
[	NULL
100	NULL
ng	NULL
!	NULL
)	NULL

of	NULL
CREB	NULL
.	NULL

CREB	NULL
and	NULL
Ets-1	NULL
bind	NULL
cooperatively	NULL
at	NULL
lower	NULL
Ets-1	NULL
concentrations	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
complex	NULL
with	NULL
reduced	NULL
mobility	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Footprinting	NULL
analyses	NULL
with	NULL
CREB	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
AML1	NULL
at	NULL
limiting	NULL
activator	NULL
concentrations	NULL
.	NULL

CREB	NULL
(	NULL
0.5	NULL
pg	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
)	NULL
,	NULL
Ets-1	NULL
(	NULL
1	NULL
pg	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
the	NULL
AML1	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
10	NULL
ng	NULL
;	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
full-length	NULL
promoter	NULL
fragment	NULL
including	NULL
positions	NULL
-83	NULL
to	NULL
+11	NULL
and	NULL
additional	NULL
restriction	NULL
sites	NULL
on	NULL
both	NULL
ends	NULL
;	NULL
DNase	NULL
I	NULL
(	NULL
40	NULL
ng	NULL
)	NULL
was	NULL
applied	NULL
for	NULL
10	NULL
s.	NULL
Binding	NULL
sites	NULL
as	NULL
deduced	NULL
from	NULL
single	NULL
activator	NULL
footprints	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
4D	NULL
,	NULL
and	NULL
5A	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

CREB	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
completely	NULL
protected	NULL
the	NULL
upstream	NULL
CRE	NULL
(	NULL
US	NULL
)	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
the	NULL
core	NULL
CRE	NULL
.	NULL

Two	NULL
hypersensitive	NULL
sites	NULL
within	NULL
the	NULL
core	NULL
promoter	NULL
are	NULL
seen	NULL
.	NULL

Addition	NULL
of	NULL
limiting	NULL
amounts	NULL
of	NULL
Ets-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
which	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
footprint	NULL
alone	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
enhanced	NULL
the	NULL
core	NULL
promoter	NULL
footprint	NULL
and	NULL
led	NULL
to	NULL
disappearance	NULL
of	NULL
the	NULL
hypersensitive	NULL
sites	NULL
induced	NULL
by	NULL
CREB	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
hypersensitive	NULL
site	NULL
at	NULL
-19	NULL
observed	NULL
in	NULL
the	NULL
Ets-1	NULL
footprint	NULL
at	NULL
saturating	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
disappeared	NULL
in	NULL
the	NULL
CREB-Ets-1	NULL
footprint	NULL
.	NULL

At	NULL
limiting	NULL
concentrations	NULL
,	NULL
combinations	NULL
of	NULL
AML1	NULL
and	NULL
Ets-1	NULL
but	NULL
not	NULL
the	NULL
individual	NULL
factors	NULL
protected	NULL
the	NULL
core	NULL
promoter	NULL
against	NULL
DNase	NULL
I	NULL
digestion	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
CREB	NULL
to	NULL
the	NULL
AML1-Ets-1	NULL
complex	NULL
further	NULL
enhanced	NULL
core	NULL
promoter	NULL
footprints	NULL
and	NULL
protected	NULL
the	NULL
upstream	NULL
CRE	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

that	NULL
the	NULL
full-length	NULL
AML1	NULL
protein	NULL
cooperates	NULL
with	NULL
CREB	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
cooperativity	NULL
is	NULL
further	NULL
amplified	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

In	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
promoter	NULL
is	NULL
completely	NULL
protected	NULL
at	NULL
low	NULL
overall	NULL
protein	NULL
concentrations	NULL
,	NULL
indicative	NULL
for	NULL
cooperativity	NULL
between	NULL
the	NULL
natural	NULL
factors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cooperativity	NULL
between	NULL
Ets-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
AML1	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
cotransfection	NULL
experiments	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Ets-1	NULL
and	NULL
CREB	NULL
stimulated	NULL
the	NULL
full-length	NULL
promoter	NULL
8-	NULL
and	NULL
6-fold	NULL
,	NULL
respectively	NULL
,	NULL
while	NULL
cotransfection	NULL
of	NULL
both	NULL
expression	NULL
vectors	NULL
yielded	NULL
a	NULL
26-fold	NULL
activation	NULL
,	NULL
thereby	NULL
exceeding	NULL
additive	NULL
effects	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Cooperativity	NULL
was	NULL
even	NULL
more	NULL
pronounced	NULL
if	NULL
limiting	NULL
amounts	NULL
of	NULL
Ets-1	NULL
and	NULL
CREB	NULL
expression	NULL
vectors	NULL
were	NULL
cotransfected	NULL
(	NULL
2.5-	NULL
and	NULL
2-fold	NULL
,	NULL
respectively	NULL
,	NULL
versus	NULL
7.5-fold	NULL
for	NULL
the	NULL
combination	NULL
[	NULL
Fig	NULL
.	NULL

8BJ	NULL
]	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
combinations	NULL
of	NULL
AML1	NULL
with	NULL
Ets-1	NULL
and	NULL
CREB	NULL
exceeded	NULL
additive	NULL
effects	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
the	NULL
three	NULL
activators	NULL
could	NULL
stimulate	NULL
the	NULL
promoter	NULL
up	NULL
to	NULL
70-fold	NULL
.	NULL

4226	NULL
HALLE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
UJ	NULL
Saturating	NULL
Amounts	NULL
70	NULL
{	NULL
14	NULL
60	NULL
12	NULL
50	NULL
40	NULL
30	NULL
20	NULL
fold	NULL
activation	NULL
by	NULL
cotransfection	NULL
fold	NULL
activation	NULL
by	NULL
cotransfection	NULL
10	NULL
2	NULL
0	NULL
0	NULL
CREB	NULL
-	NULL
440	NULL
-	NULL
44	NULL
-	NULL
44	NULL
-	NULL
++	NULL
cREB	NULL
Ets	NULL
1	NULL
-	NULL
-	NULL
++44+	NULL
-	NULL
-	NULL
++	NULL
4+	NULL
Ets-1	NULL
AML1	NULL
-o-	NULL
-	NULL
-	NULL
444444	NULL
4+	NULL
AML1	NULL
-o	NULL
+o	NULL
-o	NULL
+o	NULL
-o	NULL
+	NULL
-o	NULL
+	NULL
-o-	NULL
t	NULL
$	NULL
-	NULL
-	NULL
+	NULL
+	NULL
Ets-1	NULL
--	NULL
o-	NULL
--	NULL
ot	NULL
ot	NULL
4+	NULL
+	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

C	NULL
Consensus	NULL
Limiting	NULL
Amounts	NULL
Sites	NULL
fold	NULL
activation	NULL
by	NULL
cotransfection	NULL
1	NULL
0	NULL
CREB	NULL
-	NULL
#	NULL
6	NULL
-	NULL
++	NULL
-	NULL
+4	NULL
+4	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Cooperative	NULL
activation	NULL
by	NULL
activators	NULL
that	NULL
function	NULL
through	NULL
the	NULL
low-affinity	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Ets-1	NULL
cooperatively	NULL
activates	NULL
with	NULL
both	NULL
CREB	NULL
and	NULL
AML1	NULL
.	NULL

Combinations	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
CREB	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
Ets-1	NULL
,	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
AML1	NULL
expression	NULL
vectors	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
full-length	NULL
promoter	NULL
construct	NULL
(	NULL
-83/+11	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cooperativity	NULL
at	NULL
limiting	NULL
amounts	NULL
of	NULL
expression	NULL
vectors	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
as	NULL
for	NULL
panel	NULL
A	NULL
,	NULL
but	NULL
amounts	NULL
of	NULL
the	NULL
individual	NULL
expression	NULL
vectors	NULL
were	NULL
reduced	NULL
fivefold	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Consensus	NULL
core	NULL
promoter	NULL
binding	NULL
sites	NULL
abolish	NULL
cooperativity	NULL
in	NULL
cotransfection	NULL
experiments	NULL
.	NULL

The	NULL
core	NULL
promoter	NULL
CREB	NULL
and	NULL
Ets-1	NULL
site	NULL
were	NULL
mutated	NULL
to	NULL
consensus	NULL
binding	NULL
sites	NULL
(	NULL
from	NULL
AAATGTCA	NULL
to	NULL
TGACGTCA	NULL
and	NULL
from	NULL
AAAATTCATT	NULL
to	NULL
ACACTTCCTG	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
stimulation	NULL
by	NULL
CREB	NULL
and	NULL
Ets-1	NULL
was	NULL
analyzed	NULL
as	NULL
for	NULL
panel	NULL
A	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
,	NULL
however	NULL
,	NULL
that	NULL
this	NULL
cooperativity	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
generate	NULL
saturating	NULL
numbers	NULL
of	NULL
core	NULL
promoter	NULL
complexes	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
promoter	NULL
responds	NULL
to	NULL
overexpression	NULL
of	NULL
the	NULL
different	NULL
factors	NULL
under	NULL
conditions	NULL
under	NULL
which	NULL
the	NULL
enhancer	NULL
is	NULL
not	NULL
further	NULL
activated	NULL
(	NULL
27	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
argues	NULL
for	NULL
the	NULL
importance	NULL
of	NULL
high-affinity	NULL
binding	NULL
sites	NULL
on	NULL
enhancers	NULL
,	NULL
despite	NULL
a	NULL
certain	NULL
degree	NULL
of	NULL
cooperativity	NULL
that	NULL
stabilizes	NULL
the	NULL
Ets-CREB-AML-promoter	NULL
complexes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
low-affinity	NULL
recognition	NULL
sites	NULL
.	NULL

When	NULL
the	NULL
low-affinity	NULL
CREB	NULL
and	NULL
Ets-1	NULL
core	NULL
promoter	NULL
binding	NULL
sites	NULL
were	NULL
changed	NULL
to	NULL
consensus	NULL
,	NULL
high-affinity	NULL
sites	NULL
,	NULL
the	NULL
promoter	NULL
activity	NULL
increased	NULL
10-fold	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

This	NULL
most	NULL
likely	NULL
indicated	NULL
enhanced	NULL
binding	NULL
of	NULL
endoge-nous	NULL
factors	NULL
to	NULL
the	NULL
improved	NULL
sites	NULL
.	NULL

Indeed	NULL
,	NULL
cotransfection	NULL
even	NULL
of	NULL
high	NULL
amounts	NULL
of	NULL
the	NULL
CREB	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
further	NULL
stimulate	NULL
the	NULL
promoter	NULL
,	NULL
arguing	NULL
for	NULL
complete	NULL
occupancy	NULL
of	NULL
the	NULL
up-mutated	NULL
CRE	NULL
.	NULL

Similarly	NULL
,	NULL
relative	NULL
activation	NULL
by	NULL
Ets-1	NULL
cotransfection	NULL
was	NULL
reduced	NULL
by	NULL
the	NULL
improved	NULL
core	NULL
promoter	NULL
binding	NULL
sites	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

8A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
consensus	NULL
sites	NULL
abolished	NULL
the	NULL
cooperativity	NULL
of	NULL
CREB	NULL
and	NULL
Ets-1	NULL
observed	NULL
on	NULL
the	NULL
wild-type	NULL
promoter	NULL
.	NULL

Hence	NULL
,	NULL
low-affinity	NULL
core	NULL
promoter	NULL
sites	NULL
allow	NULL
for	NULL
cooperative	NULL
concentration-dependent	NULL
regulation	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
whereas	NULL
high-affinity	NULL
sites	NULL
elicit	NULL
a	NULL
constitutive	NULL
activity	NULL
.	NULL

Tissue-specific	NULL
promoter	NULL
structure	NULL
is	NULL
important	NULL
for	NULL
enhancer	NULL
and	NULL
overall	NULL
gene	NULL
activity	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
TCR	NULL
B	NULL
gene	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
the	NULL
promoter	NULL
accounts	NULL
for	NULL
only	NULL
about	NULL
1	NULL
%	NULL
of	NULL
the	NULL
overall	NULL
gene	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

A	NULL
construct	NULL
comprising	NULL
positions	NULL
-83	NULL
to	NULL
+11	NULL
is	NULL
100-fold	NULL
stimulated	NULL
by	NULL
the	NULL
native	NULL
enhancer	NULL
cloned	NULL
at	NULL
a	NULL
distal	NULL
position	NULL
.	NULL

This	NULL
experiment	NULL
demonstrated	NULL
that	NULL
the	NULL
94-bp	NULL
promoter	NULL
construct	NULL
was	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
facilitate	NULL
maximal	NULL
enhancer	NULL
function	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
promoter	NULL
not	NULL
only	NULL
reduced	NULL
the	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
but	NULL
also	NULL
strongly	NULL
impaired	NULL
relative	NULL
enhancer	NULL
and	NULL
absolute	NULL
gene	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
core	NULL
promoter	NULL
regions	NULL
comprising	NULL
positions	NULL
-42	NULL
to	NULL
-9	NULL
efficiently	NULL
raised	NULL
enhancer	NULL
activity	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
regulatory	NULL
regions	NULL
at	NULL
the	NULL
promoter	NULL
,	NULL
including	NULL
T-cell-specific	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
reference	NULL
27	NULL
)	NULL
,	NULL
cooperate	NULL
with	NULL
the	NULL
enhancer	NULL
,	NULL
with	NULL
overall	NULL
gene	NULL
activity	NULL
exceeding	NULL
synergistic	NULL
levels	NULL
.	NULL

This	NULL
observation	NULL
provides	NULL
evidence	NULL
for	NULL
the	NULL
relevance	NULL
of	NULL
the	NULL
promoter	NULL
structure	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
establishes	NULL
a	NULL
mechanism	NULL
for	NULL
potentiation	NULL
of	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
TCR	NULL
B	NULL
gene	NULL
.	NULL

DISCUSSION	NULL
Many	NULL
tissue-specifically	NULL
expressed	NULL
genes	NULL
are	NULL
regulated	NULL
by	NULL
highly	NULL
structured	NULL
cell-specific	NULL
distal	NULL
enhancer	NULL
elements	NULL
.	NULL

Enhancers	NULL
act	NULL
through	NULL
promoters	NULL
that	NULL
are	NULL
frequently	NULL
controlled	NULL
by	NULL
ubiquitous	NULL
activators	NULL
and	NULL
general	NULL
transcription	NULL
factors	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
family	NULL
of	NULL
TCR	NULL
B	NULL
genes	NULL
appeared	NULL
to	NULL
employ	NULL
nonstructured	NULL
,	NULL
ubiquitous	NULL
,	NULL
weak	NULL
basal	NULL
promoters	NULL
that	NULL
contain	NULL
a	NULL
single	NULL
conserved	NULL
regulatory	NULL
CRE	NULL
.	NULL

Our	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
TCR	NULL
VB	NULL
8.1	NULL
promoter	NULL
suggests	NULL
that	NULL
this	NULL
picture	NULL
is	NULL
superficial	NULL
,	NULL
at	NULL
least	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
VB	NULL
8.1	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
previous	NULL
investigations	NULL
,	NULL
we	NULL
find	NULL
a	NULL
complex	NULL
and	NULL
tissue-specific	NULL
structure	NULL
that	NULL
is	NULL
important	NULL
for	NULL
promoter	NULL
activity	NULL
,	NULL
structurally	NULL
resembles	NULL
the	NULL
TCR	NULL
enhancers	NULL
,	NULL
and	NULL
potentiates	NULL
both	NULL
promoter	NULL
160	NULL
~	NULL
120	NULL
.	NULL

80	NULL
L	NULL
40	NULL
+	NULL
fold	NULL
activation	NULL
by	NULL
TCR	NULL
B	NULL
enhancer	NULL
-797/+26	NULL
-83/+11	NULL
42/11	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Efficient	NULL
enhancer	NULL
function	NULL
requires	NULL
regulatory	NULL
promoter	NULL
regions	NULL
.	NULL

Promoter	NULL
constructs	NULL
were	NULL
analyzed	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
TCR	NULL
B	NULL
enhancer	NULL
in	NULL
a	NULL
distal	NULL
position	NULL
(	NULL
2.5	NULL
kbp	NULL
from	NULL
the	NULL
promoter	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
stimulation	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
enhancer	NULL
is	NULL
given	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
and	NULL
enhancer	NULL
activity	NULL
.	NULL

The	NULL
core	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
here	NULL
defined	NULL
as	NULL
positions	NULL
-42	NULL
to	NULL
+11	NULL
,	NULL
harbors	NULL
several	NULL
cryptic	NULL
regulatory	NULL
elements	NULL
.	NULL

Certain	NULL
activators	NULL
such	NULL
as	NULL
Ets-1	NULL
and	NULL
CREB	NULL
are	NULL
shown	NULL
to	NULL
function	NULL
surprisingly	NULL
well	NULL
through	NULL
the	NULL
low-affinity	NULL
binding	NULL
sites	NULL
at	NULL
core	NULL
promoters	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
tissue-specific	NULL
structure	NULL
of	NULL
the	NULL
VB	NULL
promoter	NULL
appears	NULL
to	NULL
be	NULL
conserved	NULL
in	NULL
the	NULL
CD4	NULL
promoter	NULL
and	NULL
in	NULL
part	NULL
also	NULL
in	NULL
other	NULL
TCR	NULL
VRB	NULL
and	NULL
the	NULL
Va	NULL
promoters	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
observations	NULL
might	NULL
be	NULL
relevant	NULL
in	NULL
the	NULL
context	NULL
of	NULL
other	NULL
genes	NULL
.	NULL

CREB	NULL
activates	NULL
efficiently	NULL
through	NULL
cryptic	NULL
binding	NULL
sites	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

The	NULL
structure	NULL
and	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
VB	NULL
8.1	NULL
and	NULL
other	NULL
promoters	NULL
may	NULL
have	NULL
been	NULL
underestimated	NULL
in	NULL
earlier	NULL
investigations	NULL
for	NULL
two	NULL
reasons	NULL
.	NULL

First	NULL
,	NULL
many	NULL
of	NULL
the	NULL
functional	NULL
elements	NULL
may	NULL
contain	NULL
nonconsensus	NULL
low-affinity	NULL
binding	NULL
sites	NULL
for	NULL
regulatory	NULL
factors	NULL
that	NULL
are	NULL
not	NULL
detected	NULL
by	NULL
sequence	NULL
comparisons	NULL
but	NULL
are	NULL
cooperatively	NULL
bound	NULL
by	NULL
regulatory	NULL
proteins	NULL
.	NULL

Second	NULL
,	NULL
promoter	NULL
activity	NULL
is	NULL
mostly	NULL
low	NULL
,	NULL
reaching	NULL
approximately	NULL
1	NULL
%	NULL
of	NULL
the	NULL
overall	NULL
gene	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
distal	NULL
enhancers	NULL
,	NULL
making	NULL
it	NULL
difficult	NULL
to	NULL
measure	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
individual	NULL
sites	NULL
at	NULL
the	NULL
promoters	NULL
,	NULL
whose	NULL
characterization	NULL
is	NULL
now	NULL
facilitated	NULL
by	NULL
more	NULL
sensitive	NULL
reporters	NULL
.	NULL

Generally	NULL
,	NULL
low	NULL
promoter	NULL
activity	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
in	NULL
vivo	NULL
observations	NULL
ex-plaining	NULL
,	NULL
for	NULL
example	NULL
,	NULL
lack	NULL
of	NULL
TCR	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
enhancers	NULL
in	NULL
animals	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
identifying	NULL
several	NULL
tissue-specific	NULL
elements	NULL
,	NULL
we	NULL
could	NULL
also	NULL
confirm	NULL
the	NULL
contribution	NULL
of	NULL
ubiquitous	NULL
proteins	NULL
such	NULL
as	NULL
Spl	NULL
and	NULL
CREB	NULL
to	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
CRE	NULL
is	NULL
highly	NULL
conserved	NULL
,	NULL
and	NULL
also	NULL
Sp1	NULL
recognition	NULL
sites	NULL
have	NULL
been	NULL
described	NULL
in	NULL
the	NULL
context	NULL
of	NULL
others	NULL
such	NULL
as	NULL
the	NULL
TCR	NULL
Va	NULL
promoter	NULL
(	NULL
37	NULL
)	NULL
.	NULL

CREB/ATF	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
upstream	NULL
CRE	NULL
that	NULL
is	NULL
conserved	NULL
between	NULL
most	NULL
TCR	NULL
VB	NULL
promoters	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
16	NULL
,	NULL
39	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
CREB	NULL
and	NULL
also	NULL
ATF-1	NULL
activate	NULL
transcription	NULL
efficiently	NULL
through	NULL
the	NULL
core	NULL
region	NULL
but	NULL
barely	NULL
affect	NULL
promoter	NULL
activity	NULL
through	NULL
the	NULL
conserved	NULL
upstream	NULL
CRE	NULL
.	NULL

The	NULL
conserved	NULL
high-affinity	NULL
element	NULL
could	NULL
also	NULL
not	NULL
modulate	NULL
promoter	NULL
activity	NULL
in	NULL
cis	NULL
.	NULL

This	NULL
may	NULL
be	NULL
understandable	NULL
in	NULL
the	NULL
light	NULL
of	NULL
recent	NULL
investigations	NULL
which	NULL
showed	NULL
that	NULL
the	NULL
upstream	NULL
CRE	NULL
is	NULL
more	NULL
important	NULL
for	NULL
enhancer	NULL
than	NULL
for	NULL
promoter	NULL
activity	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Potentiation	NULL
of	NULL
enhancer	NULL
activity	NULL
provides	NULL
a	NULL
very	NULL
efficient	NULL
mechanism	NULL
to	NULL
raise	NULL
overall	NULL
gene	NULL
activity	NULL
,	NULL
which	NULL
exceeds	NULL
by	NULL
far	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
isolated	NULL
intact	NULL
promoter	NULL
.	NULL

Similar	NULL
functions	NULL
were	NULL
assigned	NULL
to	NULL
the	NULL
Sp1	NULL
site	NULL
and	NULL
other	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
core	NULL
promoter	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
low-affinity	NULL
CRE	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
is	NULL
surprising	NULL
,	NULL
considering	NULL
that	NULL
the	NULL
inactive	NULL
high-affinity	NULL
CRE	NULL
is	NULL
located	NULL
only	NULL
30	NULL
bp	NULL
further	NULL
upstream	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Ets-1	NULL
functioned	NULL
more	NULL
efficiently	NULL
in	NULL
the	NULL
proximity	NULL
of	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
at	NULL
both	NULL
the	NULL
VB	NULL
and	NULL
CD4	NULL
promoters	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
fully	NULL
exclude	NULL
the	NULL
involvement	NULL
of	NULL
other	NULL
regulatory	NULL
components	NULL
in	NULL
activation	NULL
of	NULL
Ets	NULL
and	NULL
CREB	NULL
through	NULL
sites	NULL
between	NULL
positions	NULL
-30	NULL
and	NULL
-10	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
,	NULL
at	NULL
the	NULL
present	NULL
time	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
for	NULL
it	NULL
.	NULL

No	NULL
additional	NULL
ubiquitous	NULL
regulatory	NULL
elements	NULL
were	NULL
detected	NULL
in	NULL
core	NULL
promoters	NULL
,	NULL
and	NULL
CREB	NULL
and	NULL
Ets-1	NULL
activated	NULL
transcription	NULL
equally	NULL
well	NULL
in	NULL
HeLa	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

On	NULL
certain	NULL
genes	NULL
,	NULL
activators	NULL
such	NULL
as	NULL
E2F	NULL
(	NULL
68	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
function	NULL
through	NULL
the	NULL
core	NULL
region	NULL
,	NULL
while	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
regulatory	NULL
sites	NULL
are	NULL
located	NULL
upstream	NULL
of	NULL
core	NULL
promoters	NULL
.	NULL

The	NULL
basal	NULL
transcription	NULL
machinery	NULL
assembles	NULL
at	NULL
core	NULL
promoters	NULL
covering	NULL
large	NULL
regions	NULL
extending	NULL
from	NULL
positions	NULL
-40	NULL
to	NULL
+20	NULL
,	NULL
or	NULL
even	NULL
further	NULL
downstream	NULL
,	NULL
in	NULL
part	NULL
on	NULL
both	NULL
sides	NULL
of	NULL
the	NULL
DNA	NULL
(	NULL
recently	NULL
reviewed	NULL
in	NULL
reference	NULL
53	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
core	NULL
activators	NULL
might	NULL
sterically	NULL
interfer	NULL
with	NULL
preinitiation	NULL
complex	NULL
assembly	NULL
and	NULL
thereby	NULL
inhibit	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
TISSUE-SPECIFIC	NULL
CORE	NULL
PROMOTER	NULL
-	NULL
4227	NULL
for	NULL
reasons	NULL
that	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
,	NULL
CREB	NULL
and	NULL
Ets-1	NULL
induce	NULL
transcription	NULL
very	NULL
efficiently	NULL
at	NULL
core	NULL
promoters	NULL
.	NULL

Tissue	NULL
specificity	NULL
of	NULL
the	NULL
VB	NULL
8.1	NULL
promoter	NULL
.	NULL

The	NULL
VB	NULL
promoter	NULL
is	NULL
targeted	NULL
by	NULL
several	NULL
tissue-specific	NULL
factors	NULL
,	NULL
including	NULL
Ets-1	NULL
,	NULL
LEF1	NULL
,	NULL
and	NULL
AML1	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
individual	NULL
elements	NULL
in	NULL
vivo	NULL
is	NULL
difficult	NULL
to	NULL
predict	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
not	NULL
yet	NULL
performed	NULL
these	NULL
studies	NULL
in	NULL
different	NULL
lymphoid	NULL
cell	NULL
lines	NULL
,	NULL
several	NULL
reasons	NULL
argue	NULL
for	NULL
their	NULL
relevance	NULL
.	NULL

Ets-1	NULL
,	NULL
LEF1	NULL
,	NULL
and	NULL
AML1	NULL
proteins	NULL
are	NULL
expressed	NULL
early	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
throughout	NULL
T-cell	NULL
development	NULL
(	NULL
9	NULL
)	NULL
.	NULL

All	NULL
factors	NULL
are	NULL
integral	NULL
parts	NULL
of	NULL
individual	NULL
,	NULL
and	NULL
some	NULL
are	NULL
integral	NULL
parts	NULL
of	NULL
all	NULL
,	NULL
members	NULL
of	NULL
the	NULL
distal	NULL
TCR	NULL
enhancer	NULL
complexes	NULL
(	NULL
9	NULL
,	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Ets-1	NULL
and	NULL
AML1	NULL
activate	NULL
the	NULL
VB	NULL
promoter	NULL
when	NULL
introduced	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
Ets-1	NULL
site	NULL
is	NULL
precisely	NULL
conserved	NULL
in	NULL
the	NULL
CD4	NULL
promoter	NULL
,	NULL
and	NULL
ETS-like	NULL
elements	NULL
have	NULL
been	NULL
found	NULL
in	NULL
the	NULL
TCR	NULL
VB	NULL
2	NULL
and	NULL
the	NULL
TCR	NULL
V8	NULL
1	NULL
promoters	NULL
(	NULL
48	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Specific	NULL
binding	NULL
,	NULL
the	NULL
conservation	NULL
of	NULL
the	NULL
recognition	NULL
site	NULL
,	NULL
and	NULL
the	NULL
T-cell	NULL
specificity	NULL
of	NULL
the	NULL
elements	NULL
surrounding	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
suggest	NULL
a	NULL
role	NULL
of	NULL
the	NULL
group	NULL
of	NULL
LEF/TCF	NULL
HMG	NULL
box	NULL
proteins	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
VB	NULL
promoter	NULL
.	NULL

Different	NULL
members	NULL
of	NULL
the	NULL
HMG	NULL
box	NULL
proteins	NULL
have	NULL
been	NULL
isolated	NULL
;	NULL
some	NULL
are	NULL
found	NULL
in	NULL
various	NULL
tissues	NULL
,	NULL
which	NULL
could	NULL
complicate	NULL
the	NULL
analysis	NULL
of	NULL
defined	NULL
proteins	NULL
such	NULL
as	NULL
LEF1	NULL
(	NULL
12	NULL
,	NULL
74	NULL
,	NULL
75	NULL
,	NULL
77	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
LEF1	NULL
requires	NULL
other	NULL
components	NULL
present	NULL
in	NULL
the	NULL
genomic	NULL
environment	NULL
or	NULL
exhibits	NULL
a	NULL
more	NULL
complex	NULL
architectural	NULL
role	NULL
which	NULL
might	NULL
not	NULL
be	NULL
detectable	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
20	NULL
,	NULL
65	NULL
)	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
we	NULL
also	NULL
found	NULL
ubiquitous	NULL
proteins	NULL
that	NULL
raise	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
influence	NULL
of	NULL
lymphoid	NULL
factors	NULL
was	NULL
underestimated	NULL
by	NULL
using	NULL
the	NULL
SV40	NULL
promoter	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

The	NULL
SV40	NULL
promoter	NULL
is	NULL
activated	NULL
by	NULL
Sp1	NULL
(	NULL
13	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
present	NULL
in	NULL
high	NULL
concentrations	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Further	NULL
in	NULL
support	NULL
of	NULL
this	NULL
as-sumption	NULL
,	NULL
normalization	NULL
of	NULL
luciferase	NULL
activities	NULL
to	NULL
CMV	NULL
promoter	NULL
activities	NULL
yielded	NULL
even	NULL
higher	NULL
activities	NULL
of	NULL
the	NULL
VB	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Earlier	NULL
investigations	NULL
,	NULL
indicating	NULL
T-cell-specific	NULL
elements	NULL
at	NULL
the	NULL
VB	NULL
promoter	NULL
without	NULL
defining	NULL
factors	NULL
acting	NULL
through	NULL
these	NULL
upstream	NULL
elements	NULL
(	NULL
11	NULL
,	NULL
60	NULL
)	NULL
,	NULL
were	NULL
not	NULL
confirmed	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
.	NULL

Cooperativity	NULL
at	NULL
the	NULL
core	NULL
promoter	NULL
and	NULL
between	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

Ets-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
AML1	NULL
bind	NULL
and	NULL
activate	NULL
transcription	NULL
cooperatively	NULL
at	NULL
the	NULL
VB	NULL
core	NULL
promoter	NULL
.	NULL

This	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
TCRa	NULL
«	NULL
and	NULL
other	NULL
TCR	NULL
enhancers	NULL
(	NULL
20	NULL
,	NULL
79	NULL
)	NULL
on	NULL
which	NULL
Ets-1	NULL
and	NULL
AML1	NULL
bind	NULL
cooperatively	NULL
to	NULL
adjacent	NULL
sites	NULL
.	NULL

Here	NULL
we	NULL
also	NULL
describe	NULL
cooperativity	NULL
between	NULL
Ets-1	NULL
and	NULL
CREB	NULL
in	NULL
both	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
.	NULL

This	NULL
was	NULL
not	NULL
evident	NULL
in	NULL
earlier	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
studies	NULL
,	NULL
conducted	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
,	NULL
in	NULL
which	NULL
Ets-1	NULL
interacted	NULL
specifically	NULL
with	NULL
ATF-2	NULL
(	NULL
20	NULL
)	NULL
.	NULL

While	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
a	NULL
role	NULL
of	NULL
ATF-2	NULL
at	NULL
the	NULL
promoter	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
cooperativity	NULL
between	NULL
Ets-1	NULL
and	NULL
CREB	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
two	NULL
adjacent	NULL
DNA	NULL
recognition	NULL
sites	NULL
.	NULL

Somewhat	NULL
surprising	NULL
,	NULL
Ets-1	NULL
but	NULL
not	NULL
by	NULL
Elf-1	NULL
acted	NULL
through	NULL
the	NULL
core	NULL
promoters	NULL
,	NULL
which	NULL
is	NULL
not	NULL
expected	NULL
from	NULL
the	NULL
binding	NULL
site	NULL
at	NULL
the	NULL
promoter	NULL
(	NULL
76	NULL
)	NULL
.	NULL

This	NULL
may	NULL
indicate	NULL
that	NULL
regions	NULL
other	NULL
than	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
are	NULL
involved	NULL
in	NULL
cooperative	NULL
interactions	NULL
at	NULL
core	NULL
promoters	NULL
.	NULL

Alter-natively	NULL
,	NULL
Elf-1	NULL
may	NULL
not	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
activate	NULL
transcription	NULL
at	NULL
core	NULL
promoters	NULL
.	NULL

Cooperativity	NULL
probably	NULL
facilitates	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
low-affinity	NULL
sites	NULL
and	NULL
thereby	NULL
potentiates	NULL
tissue-specific	NULL
transcription	NULL
.	NULL

For	NULL
example	NULL
,	NULL
CREB	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
,	NULL
Ets-1	NULL
is	NULL
expressed	NULL
in	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
hematopoietic	NULL
expression	NULL
of	NULL
AML1	NULL
is	NULL
restricted	NULL
to	NULL
thymocytes	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Interactions	NULL
between	NULL
the	NULL
proteins	NULL
that	NULL
promote	NULL
complex	NULL
assembly	NULL
might	NULL
also	NULL
support	NULL
looping	NULL
of	NULL
distal	NULL
enhancers	NULL
toward	NULL
promoters	NULL
(	NULL
3	NULL
,	NULL
41	NULL
,	NULL
45	NULL
,	NULL
54	NULL
,	NULL
57	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
increasing	NULL
numbers	NULL
of	NULL
regulatory	NULL
4228	NULL
HALLE	NULL
ET	NULL
AL	NULL
.	NULL

elements	NULL
located	NULL
in	NULL
the	NULL
core	NULL
promoter	NULL
regions	NULL
of	NULL
enhancer-regulated	NULL
genes	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
34	NULL
,	NULL
62	NULL
,	NULL
81	NULL
)	NULL
,	NULL
cooperation	NULL
between	NULL
activators	NULL
on	NULL
the	NULL
core	NULL
promoter	NULL
and	NULL
the	NULL
enhancer	NULL
may	NULL
not	NULL
be	NULL
restricted	NULL
to	NULL
TCR	NULL
genes	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
promoter	NULL
structure	NULL
is	NULL
important	NULL
for	NULL
enhancer	NULL
activity	NULL
,	NULL
as	NULL
the	NULL
complete	NULL
but	NULL
not	NULL
a	NULL
minimal	NULL
promoter	NULL
is	NULL
efficiently	NULL
activated	NULL
by	NULL
the	NULL
distal	NULL
TCR	NULL
VRB	NULL
enhancer	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

While	NULL
we	NULL
have	NULL
not	NULL
investigated	NULL
physical	NULL
enhancer-promoter	NULL
interactions	NULL
,	NULL
potentiation	NULL
of	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
regulatory	NULL
promoter	NULL
regions	NULL
clearly	NULL
underlines	NULL
the	NULL
relevance	NULL
of	NULL
this	NULL
promoter	NULL
study	NULL
and	NULL
establishes	NULL
an	NULL
intriguing	NULL
mechanism	NULL
for	NULL
amplification	NULL
and	NULL
regulation	NULL
of	NULL
T-cell-specific	NULL
transcription	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
G.	NULL
Schiitz	NULL
,	NULL
R.	NULL
Grosschedl	NULL
,	NULL
M.	NULL
R.	NULL
Montminy	NULL
,	NULL
K.	NULL
Giese	NULL
,	NULL
H.	NULL
Clevers	NULL
,	NULL
Y.	NULL
Ito	NULL
,	NULL
M.	NULL
Roussel	NULL
,	NULL
H.	NULL
Stunnenberg	NULL
,	NULL
S.	NULL
Smale	NULL
,	NULL
G.	NULL
Suske	NULL
,	NULL
and	NULL
L.	NULL
Weiss	NULL
for	NULL
expression	NULL
plasmids	NULL
and	NULL
members	NULL
of	NULL
the	NULL
LMB-Genzentrum	NULL
for	NULL
materials	NULL
and	NULL
helpful	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
BMBF	NULL
to	NULL
M.M	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Anderson	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
H.	NULL
S.	NULL
Chou	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
conserved	NULL
sequence	NULL
in	NULL
the	NULL
T-cell	NULL
receptor	NULL
B-chain	NULL
promoter	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:3551-3554	NULL
.	NULL

2	NULL
.	NULL

Anderson	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
S.	NULL
Miyake	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Lob	NULL
.	NULL

1989	NULL
.	NULL

Transcription	NULL
from	NULL
a	NULL
murine	NULL
T-cell	NULL
receptor	NULL
VB	NULL
promoter	NULL
depends	NULL
on	NULL
a	NULL
conserved	NULL
decamer	NULL
motif	NULL
similar	NULL
to	NULL
the	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:4835-4845	NULL
.	NULL

3	NULL
.	NULL

Artandi	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
C.	NULL
Cooper	NULL
,	NULL
A.	NULL
Shrivastava	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
basic	NULL
helix-loop-helix-zipper	NULL
domain	NULL
of	NULL
TFE3	NULL
mediates	NULL
enhancer-promoter	NULL
inter-action	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7704-7716	NULL
.	NULL

4	NULL
.	NULL

Banerji	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Olson	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
lymphocyte-specific	NULL
cellular	NULL
enhancer	NULL
is	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
joining	NULL
region	NULL
in	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
genes	NULL
.	NULL

Cell	NULL
33:729-740	NULL
.	NULL

5	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
Koizumi	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1990	NULL
.	NULL

Reciprocal	NULL
expression	NULL
of	NULL
human	NULL
ETS1	NULL
and	NULL
ETS2	NULL
genes	NULL
during	NULL
T-cell	NULL
activation	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
the	NULL
protooncogene	NULL
ETS1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:3723-3727	NULL
.	NULL

6	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
K.	NULL
L.	NULL
Komschlies	NULL
,	NULL
S.	NULL
Fujiwara	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
B.	NULL
J.	NULL
Mathieson	NULL
,	NULL
T.	NULL
A.	NULL
Gregorio	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
J.	NULL
W.	NULL
Kasik	NULL
,	NULL
K.	NULL
Ozato	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
ets	NULL
genes	NULL
in	NULL
mouse	NULL
thymocyte	NULL
subsets	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:672-678	NULL
.	NULL

7	NULL
.	NULL

Clausell	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Tucker	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
Vy3	NULL
promoter	NULL
of	NULL
the	NULL
murine	NULL
y8	NULL
T-cell	NULL
receptor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:803-814	NULL
.	NULL

8	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
Lonberg	NULL
,	NULL
S.	NULL
Dunlap	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1989	NULL
.	NULL

An	NULL
enhancer	NULL
located	NULL
in	NULL
a	NULL
CpG-island	NULL
3	NULL
'	NULL
to	NULL
the	NULL
TCR/CD3-epsilon	NULL
gene	NULL
confers	NULL
T	NULL
lymphocyte-specificity	NULL
to	NULL
its	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

§:2527-2535	NULL
.	NULL

9	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
and	NULL
R.	NULL
Grossched	NULL
]	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
control	NULL
of	NULL
lymphoid	NULL
development	NULL
:	NULL
lessons	NULL
from	NULL
gene	NULL
targeting	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:336-343	NULL
.	NULL

10	NULL
.	NULL

Davis	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Roussel	NULL
.	NULL

1996	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
murine	NULL
Elf-1	NULL
cDNA	NULL
.	NULL

Gene	NULL
171:265-269	NULL
.	NULL

11	NULL
.	NULL

Diamond	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
F.	NULL
B.	NULL
Nelson	NULL
,	NULL
and	NULL
E.	NULL
L.	NULL
Reinherz	NULL
.	NULL

1989	NULL
.	NULL

Lincage-specific	NULL
expression	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
receptor	NULL
variable	NULL
gene	NULL
promoter	NULL
controlled	NULL
by	NULL
upstream	NULL
sequences	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169:1213-1231	NULL
.	NULL

12	NULL
.	NULL

Dunn	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
L.	NULL
Mynett-Johnson	NULL
,	NULL
E.	NULL
M.	NULL
Wright	NULL
,	NULL
B.	NULL
M.	NULL
Hosking	NULL
,	NULL
P.	NULL
A.	NULL
Koop-man	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
O.	NULL
Muscat	NULL
.	NULL

1995	NULL
.	NULL

Sequence	NULL
and	NULL
expression	NULL
of	NULL
Sox-18	NULL
encoding	NULL
a	NULL
new	NULL
HMG-box	NULL
transcription	NULL
factor	NULL
.	NULL

Gene	NULL
161:223-225	NULL
.	NULL

13	NULL
.	NULL

Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
promoter-specific	NULL
transcription	NULL
factor	NULL
Sp1	NULL
binds	NULL
to	NULL
upstream	NULL
sequences	NULL
in	NULL
the	NULL
SV40	NULL
carly	NULL
promoter	NULL
.	NULL

Cell	NULL
35:79-87	NULL
.	NULL

14	NULL
.	NULL

Franke	NULL
,	NULL
S.	NULL
,	NULL
G.	NULL
Scholz	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
novel	NULL
ubiquitous	NULL
and	NULL
cell	NULL
type-specific	NULL
factors	NULL
that	NULL
specifically	NULL
recognize	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
and	NULL
kappa	NULL
light	NULL
chain	NULL
promoters	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
:	NULL
20075-20082	NULL
.	NULL

15	NULL
.	NULL

Franklin	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
G.	NULL
I	NULL
Adam	NULL
,	NULL
S.	NULL
J.	NULL
Miller	NULL
,	NULL
C.	NULL
L.	NULL
Moncrieff	NULL
,	NULL
E.	NULL
Ulleras	NULL
,	NULL
and	NULL
R.	NULL
Ohlsson	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
Inr-containing	NULL
sequence	NULL
flanking	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
human	NULL
e-sis	NULL
(	NULL
PDGF-B	NULL
)	NULL
proto-oncogene	NULL
promoter	NULL
functions	NULL
in	NULL
cis	NULL
as	NULL
a	NULL
co-activator	NULL
for	NULL
its	NULL
intronic	NULL
enhancer	NULL
.	NULL

Oncogene	NULL
11:1873-1884	NULL
.	NULL

16	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Morgan	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Moore	NULL
.	NULL

1992	NULL
.	NULL

Functionally	NULL
distinct	NULL
isoforms	NULL
of	NULL
the	NULL
CRE-BP	NULL
DNA-binding	NULL
protein	NULL
mediate	NULL
activity	NULL
of	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:747-757	NULL
.	NULL

17	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
and	NULL
B.	NULL
Derfler	NULL
.	NULL

1992	NULL
.	NULL

Ikaros	NULL
an	NULL
carly	NULL
T	NULL
cell	NULL
restricted	NULL
transcription	NULL
factor	NULL
:	NULL
a	NULL
putative	NULL
mediator	NULL
for	NULL
T	NULL
cell	NULL
commitment	NULL
.	NULL

Science	NULL
258:808-812	NULL
.	NULL

18	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
P.	NULL
van	NULL
den	NULL
Elsen	NULL
,	NULL
E.	NULL
Bier	NULL
,	NULL
A.	NULL
Maxam	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
T	NULL
cell-specific	NULL
enhancer	NULL
is	NULL
located	NULL
in	NULL
a	NULL
DNase	NULL
I-hypersensitive	NULL
area	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
CD3-delta	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:2401-2407	NULL
.	NULL

19	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Cox	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
HMG	NULL
domain	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
bends	NULL
DNA	NULL
and	NULL
facilitates	NULL
assembly	NULL
of	NULL
functional	NULL
nucleo-protein	NULL
structures	NULL
.	NULL

Cell	NULL
69:185-195	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Kingsley	NULL
,	NULL
J.	NULL
R.	NULL
Kirshner	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1995	NULL
.	NULL

Assembly	NULL
and	NULL
function	NULL
of	NULL
a	NULL
TCR	NULL
alpha	NULL
enhancer	NULL
complex	NULL
is	NULL
dependent	NULL
on	NULL
LEF-1-induced	NULL
DNA	NULL
bending	NULL
and	NULL
multiple	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:995-1008	NULL
.	NULL

Gonzalez	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1989	NULL
.	NULL

Cyclic	NULL
AMP	NULL
stimulates	NULL
soma-tostatin	NULL
gene	NULL
transcription	NULL
by	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
serine	NULL
133	NULL
.	NULL

Cell	NULL
59:675-680	NULL
.	NULL

Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
B-gene	NULL
transcriptional	NULL
en-hancer	NULL
:	NULL
common	NULL
nuclear	NULL
proteins	NULL
interact	NULL
with	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
«	NULL
and	NULL
B	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5486-5495	NULL
.	NULL

Graves	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
M.	NULL
E.	NULL
Gillespie	NULL
,	NULL
and	NULL
L.	NULL
P.	NULL
Mcintosh	NULL
.	NULL

1996	NULL
.	NULL

DNA	NULL
binding	NULL
by	NULL
the	NULL
ETS	NULL
domain	NULL
.	NULL

Nature	NULL
384:322	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Miller	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
G.	NULL
Suske	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
by	NULL
recognition	NULL
site	NULL
screening	NULL
of	NULL
two	NULL
novel	NULL
GT	NULL
box	NULL
binding	NULL
proteins	NULL
:	NULL
a	NULL
family	NULL
of	NULL
Sp1	NULL
related	NULL
genes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:5519-5525	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Miller	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
G.	NULL
Suske	NULL
.	NULL

1994	NULL
.	NULL

Spi-mediated	NULL
transcriptional	NULL
activation	NULL
is	NULL
repressed	NULL
by	NULL
Sp3	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:3843-3851	NULL
.	NULL

Halle	NULL
,	NULL
J.-P.	NULL
,	NULL
G.	NULL
Stelzer	NULL
,	NULL
A.	NULL
Goppelt	NULL
,	NULL
and	NULL
M.	NULL
Meisterernst	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
recombinant	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
1	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
novel	NULL
positive	NULL
cofactor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:21307-21311	NULL
.	NULL

Halle	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
Haus-Seuffert	NULL
,	NULL
C.	NULL
Woltering	NULL
,	NULL
and	NULL
M.	NULL
Meisterernst	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
S.	NULL
McDougall	NULL
,	NULL
J.	NULL
Leiden	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Calame	NULL
.	NULL

1994	NULL
.	NULL

GATA	NULL
elements	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
activity	NULL
and	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
beta-chain	NULL
transcriptional	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4286-4294	NULL
.	NULL

Hettmann	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
A.	NULL
Cohen	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
T	NULL
cell-specific	NULL
transcriptional	NULL
enhancer	NULL
3	NULL
'	NULL
of	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
gamma	NULL
locus	NULL
.	NULL

Mol	NULL
.	NULL

Immunol	NULL
.	NULL

31:315-322	NULL
.	NULL

Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
W.	NULL
Sun	NULL
,	NULL
J.	NULL
N.	NULL
Davis	NULL
,	NULL
T.	NULL
Golub	NULL
,	NULL
S.	NULL
Shurtleff	NULL
,	NULL
A.	NULL
Buijs	NULL
,	NULL
J.	NULL
R.	NULL
Downing	NULL
,	NULL
G.	NULL
Grosveld	NULL
,	NULL
M.	NULL
F.	NULL
Roussell	NULL
,	NULL
D.	NULL
G.	NULL
Gilliland	NULL
,	NULL
N.	NULL
Lenny	NULL
,	NULL
and	NULL
S.	NULL
Meyers	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
converts	NULL
AML-1B	NULL
from	NULL
an	NULL
activator	NULL
to	NULL
a	NULL
repressor	NULL
of	NULL
transcription	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1349-1355	NULL
.	NULL

Ho	NULL
,	NULL
L-C.	NULL
,	NULL
L.-H.	NULL
Yang	NULL
,	NULL
G.	NULL
Morle	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancer	NULL
element	NULL
3	NULL
'	NULL
of	NULL
C	NULL
alpha	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
alpha	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6714-6718	NULL
.	NULL

Holstege	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
D.	NULL
Tantin	NULL
,	NULL
M.	NULL
Carey	NULL
,	NULL
P.	NULL
C.	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
and	NULL
H.	NULL
T.	NULL
Timmers	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
the	NULL
basal	NULL
transcription	NULL
factor	NULL
IIE	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
helical	NULL
stability	NULL
of	NULL
promoter	NULL
DNA	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:810-819	NULL
.	NULL

Javahery	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Khachi	NULL
,	NULL
K.	NULL
Lo	NULL
,	NULL
B.	NULL
Zenzie-Gregory	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Smale	NULL
.	NULL

1994	NULL
.	NULL

DNA	NULL
sequence	NULL
requirements	NULL
for	NULL
transcription	NULL
initiator	NULL
activity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:116-127	NULL
.	NULL

Jiang	NULL
,	NULL
S.-W.	NULL
,	NULL
A.	NULL
R.	NULL
Shepard	NULL
,	NULL
and	NULL
N.	NULL
L.	NULL
Eberhardt	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
initiator	NULL
clement	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
human	NULL
chorionic	NULL
somatomammotropin	NULL
gene	NULL
promoter	NULL
and	NULL
enhancer	NULL
function	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:3683-3692	NULL
.	NULL

Jonsen	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
J.	NULL
M.	NULL
Petersen	NULL
,	NULL
Q.-P.	NULL
Xu	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
cooperative	NULL
function	NULL
of	NULL
inhibitory	NULL
sequences	NULL
in	NULL
Ets-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2065-2073	NULL
.	NULL

Kekule	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
U.	NULL
Laver	NULL
,	NULL
L.	NULL
Weiss	NULL
,	NULL
B.	NULL
Luber	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Hofschneider	NULL
.	NULL

1993	NULL
.	NULL

Hepatitis	NULL
B	NULL
virus	NULL
transactivator	NULL
HBx	NULL
uses	NULL
a	NULL
tumour	NULL
promoter	NULL
signalling	NULL
pathway	NULL
.	NULL

Nature	NULL
361:742-745	NULL
.	NULL

Kingsley	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
A.	NULL
Winoto	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
GT	NULL
box-binding	NULL
proteins	NULL
:	NULL
a	NULL
novel	NULL
Sp1	NULL
multigene	NULL
family	NULL
regulating	NULL
T-cell	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4251-4261	NULL
.	NULL

Krimpenfort	NULL
,	NULL
P.	NULL
,	NULL
R.	NULL
de	NULL
Jong	NULL
,	NULL
Y.	NULL
Uematsu	NULL
,	NULL
Z.	NULL
Dembic	NULL
,	NULL
S.	NULL
Ryser	NULL
,	NULL
H.	NULL
von	NULL
Boehmer	NULL
,	NULL
M.	NULL
Steinmetz	NULL
,	NULL
and	NULL
A.	NULL
Berns	NULL
.	NULL

1988	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
B-chain	NULL
gene	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
downstream	NULL
regulatory	NULL
element	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:745-750	NULL
.	NULL

Lee	NULL
,	NULL
M.-R.	NULL
,	NULL
C.-S.	NULL
Chung	NULL
,	NULL
M.-L.	NULL
Liou	NULL
,	NULL
M.	NULL
Wu	NULL
,	NULL
W.-F.	NULL
Li	NULL
,	NULL
Y.-P.	NULL
Hsueh	NULL
,	NULL
and	NULL
M.-Z	NULL
.	NULL

Lai	NULL
.	NULL

1992	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
T	NULL
cell	NULL
receptor	NULL
VB	NULL
decamer	NULL
motif	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1906-1912	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
1993	NULL
.	NULL

Transcription	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:539-570	NULL
.	NULL

Li	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
D.	NULL
Knight	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
R.	NULL
Tjian	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Botchan	NULL
.	NULL

1991	NULL
.	NULL

Direct	NULL
interaction	NULL
between	NULL
Sp1	NULL
and	NULL
BPV	NULL
enhancer	NULL
E2	NULL
protein	NULL
mediates	NULL
synergistic	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

Cell	NULL
65:493-505	NULL
.	NULL

Manzano-Winkler	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
D.	NULL
Novina	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
Roy	NULL
.	NULL

1996	NULL
.	NULL

TFII-I	NULL
is	NULL
required	NULL
for	NULL
transcription	NULL
of	NULL
the	NULL
naturally	NULL
TATA-less	NULL
but	NULL
initiator-containing	NULL
VB	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:12076-12081	NULL
.	NULL

Marine	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
Winoto	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
human	NULL
enhancer-binding	NULL
protein	NULL
Gata3	NULL
binds	NULL
to	NULL
several	NULL
T-cell	NULL
receptor	NULL
regulatory	NULL
elements	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7284-7288	NULL
.	NULL

Maroulakou	NULL
,	NULL
I.	NULL
G.	NULL
,	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Green	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
ets-1	NULL
and	NULL
ets-2	NULL
proto-oncogenes	NULL
during	NULL
murine	NULL
embryogenesis	NULL
.	NULL

Oncogene	NULL
9:1551-1565	NULL
.	NULL

Mastrangelo	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
,	NULL
A.	NULL
J.	NULL
Courey	NULL
,	NULL
J.	NULL
S.	NULL
Wall	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
and	NULL
P.	NULL
V.	NULL
C.	NULL
Hough	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
looping	NULL
and	NULL
Sp1	NULL
multimer	NULL
links	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
synergism	NULL
and	NULL
enhancement	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5670-5674	NULL
.	NULL

McDougall	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
L.	NULL
Peterson	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
transcriptional	NULL
enhancer	NULL
3	NULL
'	NULL
of	NULL
CB2	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
B	NULL
locus	NULL
.	NULL

Science	NULL
241:205-241	NULL
.	NULL

Meisterernst	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
L.	NULL
Roy	NULL
,	NULL
H.	NULL
M.	NULL
Lieu	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65.	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
by	NULL
regulatory	NULL
factors	NULL
is	NULL
potentiated	NULL
by	NULL
a	NULL
novel	NULL
activity	NULL
.	NULL

Cell	NULL
66:981-993	NULL
.	NULL

Messier	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Ratanavongsiri	NULL
,	NULL
T.	NULL
Fuller	NULL
,	NULL
S.	NULL
Mangal	NULL
,	NULL
P.	NULL
Kilgannon	NULL
,	NULL
R.	NULL
Fotedar	NULL
,	NULL
and	NULL
A.	NULL
Fotedar	NULL
.	NULL

1992	NULL
.	NULL

Mapping	NULL
of	NULL
an	NULL
inducible	NULL
element	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
VB	NULL
2	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:1980-1986	NULL
.	NULL

Molnar	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
Georgopoulos	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Ikaros	NULL
gene	NULL
encodes	NULL
a	NULL
family	NULL
of	NULL
functionally	NULL
diverse	NULL
zinc	NULL
finger	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
:	NULL
8292-8303	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Rowley	NULL
.	NULL

1995	NULL
.	NULL

AML1	NULL
and	NULL
the	NULL
8	NULL
;	NULL
21	NULL
and	NULL
3	NULL
;	NULL
21	NULL
translo-cations	NULL
in	NULL
acute	NULL
and	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Blood	NULL
86:1-14	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
M.	NULL
Petersen	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
M.	NULL
D.	NULL
Jonsen	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
murine	NULL
ets-1	NULL
with	NULL
GGA-binding	NULL
sites	NULL
establishes	NULL
the	NULL
ETS	NULL
domain	NULL
as	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:975-990	NULL
.	NULL

Ogawa	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
H.	NULL
Kagoshima	NULL
,	NULL
M.	NULL
Inuzuka	NULL
,	NULL
J.	NULL
Lu	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
K.	NULL
Shigesada	NULL
,	NULL
and	NULL
Y.	NULL
Ito	NULL
.	NULL

1993	NULL
.	NULL

PEBP2/PEA2	NULL
represents	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
homologous	NULL
to	NULL
the	NULL
products	NULL
of	NULL
the	NULL
Drosophila	NULL
runt	NULL
gene	NULL
and	NULL
the	NULL
human	NULL
AML1	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:6859-6863	NULL
.	NULL

Orphanides	NULL
,	NULL
G.	NULL
,	NULL
T.	NULL
Lagrange	NULL
,	NULL
and	NULL
D.	NULL
Reinberg	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
general	NULL
transcription	NULL
factors	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2657-2683	NULL
.	NULL

Pascal	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1991	NULL
.	NULL

Different	NULL
activation	NULL
domains	NULL
of	NULL
Sp1	NULL
govern	NULL
formation	NULL
of	NULL
multimers	NULL
and	NULL
mediate	NULL
transcriptional	NULL
synergism	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1646-1656	NULL
.	NULL

Pognonec	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
E.	NULL
Boulukos	NULL
,	NULL
J.	NULL
C.	NULL
Gesquiere	NULL
,	NULL
D.	NULL
Stehelin	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1988	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
thymocytes	NULL
results	NULL
in	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
c-ets-1	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:977-983	NULL
.	NULL

Prosser	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
D.	NULL
Wotton	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
phorbol	NULL
ester	NULL
element	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
B-chain	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:9934-9938	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
1986	NULL
.	NULL

Gene	NULL
regulation	NULL
by	NULL
proteins	NULL
acting	NULL
nearby	NULL
and	NULL
at	NULL
a	NULL
distance	NULL
.	NULL

Nature	NULL
322:697-701	NULL
.	NULL

Punturieri	NULL
,	NULL
A.	NULL
,	NULL
Y.	NULL
Shirakata	NULL
,	NULL
C.	NULL
Bovolenta	NULL
,	NULL
G.	NULL
Kikuchi	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Colignan	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
cis-acting	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
transcription	NULL
of	NULL
the	NULL
mouse	NULL
V	NULL
delta	NULL
1	NULL
T	NULL
cell	NULL
receptor	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:139-150	NULL
.	NULL

Rowen	NULL
,	NULL
L.	NULL
,	NULL
B.	NULL
F.	NULL
Koop	NULL
,	NULL
and	NULL
L.	NULL
Hood	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
complete	NULL
685-kilobase	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
beta	NULL
T	NULL
cell	NULL
receptor	NULL
locus	NULL
.	NULL

Science	NULL
272:1755-1762	NULL
.	NULL

Royer	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
L.	NULL
Reinherz	NULL
.	NULL

1987	NULL
.	NULL

Multiple	NULL
nuclear	NULL
proteins	NULL
bind	NULL
upstream	NULL
sequences	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
a	NULL
T-cell	NULL
receptor	NULL
beta-chain	NULL
variable-region	NULL
gene	NULL
:	NULL
evidence	NULL
for	NULL
tissue	NULL
specificity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:232-236	NULL
.	NULL

Saffer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Annarella	NULL
.	NULL

1991	NULL
.	NULL

Developmental	NULL
expression	NULL
of	NULL
Sp1	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2189-2199	NULL
.	NULL

Salmon	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Giovane	NULL
,	NULL
B.	NULL
Wasylyk	NULL
,	NULL
and	NULL
D.	NULL
Klatzmann	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
CD4	NULL
gene	NULL
promoter	NULL
:	NULL
transcription	NULL
from	NULL
the	NULL
CD4	NULL
gene	NULL
core	NULL
promoter	NULL
is	NULL
tissue-specific	NULL
and	NULL
is	NULL
activated	NULL
by	NULL
Ets	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7739-7743	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Sawada	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
adjacent	NULL
to	NULL
the	NULL
murine	NULL
CD4	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5506-5515	NULL
.	NULL

Sheridan	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
C.	NULL
T.	NULL
Sheline	NULL
,	NULL
K.	NULL
Cannon	NULL
,	NULL
M.	NULL
L.	NULL
Voz	NULL
,	NULL
M.	NULL
J.	NULL
Pazin	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
the	NULL
66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

TISSUE-SPECIFIC	NULL
CORE	NULL
PROMOTER	NULL
-	NULL
4229	NULL
LEF-1	NULL
HMG	NULL
protein	NULL
on	NULL
nucleosome-assembled	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:2090-2104	NULL
.	NULL

Sin	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
C.	NULL
Strauss	NULL
,	NULL
E.	NULL
Lai	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Hood	NULL
.	NULL

1986	NULL
.	NULL

Analysis	NULL
of	NULL
a	NULL
human	NULL
VB	NULL
gene	NULL
subfamily	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164:1600-1614	NULL
.	NULL

Sjottem	NULL
,	NULL
E.	NULL
,	NULL
S.	NULL
Anderssen	NULL
,	NULL
and	NULL
T.	NULL
Johansen	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
promoter	NULL
activity	NULL
of	NULL
long	NULL
terminal	NULL
repeats	NULL
of	NULL
the	NULL
HERV-H	NULL
family	NULL
of	NULL
human	NULL
retrovirus-like	NULL
elements	NULL
is	NULL
critically	NULL
dependent	NULL
on	NULL
Spl	NULL
family	NULL
proteins	NULL
interacting	NULL
with	NULL
a	NULL
GC/GT	NULL
box	NULL
located	NULL
immediately	NULL
3	NULL
'	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:188-198	NULL
.	NULL

Slasky	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Y.	NULL
Li	NULL
,	NULL
W.	NULL
G.	NULL
Kaelin	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farnham	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
protein	NULL
synthesis-dependent	NULL
increase	NULL
in	NULL
E2F1	NULL
mRNA	NULL
correlates	NULL
with	NULL
growth	NULL
regulation	NULL
of	NULL
the	NULL
dihydrofolate	NULL
reductase	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1610-1618	NULL
.	NULL

Slightom	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
D.	NULL
R.	NULL
Siemieniak	NULL
,	NULL
L.	NULL
C.	NULL
Sieu	NULL
,	NULL
B.	NULL
F.	NULL
Koop	NULL
,	NULL
and	NULL
L.	NULL
Hood	NULL
.	NULL

1994	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
analysis	NULL
of	NULL
77.7	NULL
kb	NULL
of	NULL
the	NULL
human	NULL
VB	NULL
T-cell	NULL
receptor	NULL
gene	NULL
locus	NULL
:	NULL
direct	NULL
primer-walking	NULL
using	NULL
cosmid	NULL
template	NULL
DNAs	NULL
.	NULL

Genomics	NULL
20:149-168	NULL
.	NULL

Stelzer	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Goppelt	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
and	NULL
M.	NULL
Meisterernst	NULL
.	NULL

1994	NULL
.	NULL

Basal	NULL
repression	NULL
by	NULL
HMG2	NULL
is	NULL
counteracted	NULL
by	NULL
TFIIH-associated	NULL
factors	NULL
in	NULL
an	NULL
ATP-dependent	NULL
process	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4712-4721	NULL
.	NULL

Su	NULL
,	NULL
W.	NULL
,	NULL
S.	NULL
Jackson	NULL
,	NULL
R.	NULL
Tjian	NULL
,	NULL
and	NULL
H.	NULL
Echols	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
looping	NULL
between	NULL
sites	NULL
for	NULL
transcriptional	NULL
activation	NULL
:	NULL
self-association	NULL
of	NULL
DNA-bound	NULL
SP1	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:820-826	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Virus	NULL
induction	NULL
of	NULL
human	NULL
IFN	NULL
beta	NULL
gene	NULL
expression	NULL
requires	NULL
the	NULL
assembly	NULL
of	NULL
an	NULL
enhanceosome	NULL
.	NULL

Cell	NULL
83:1091-1100	NULL
.	NULL

Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

Transcriptional	NULL
activation	NULL
:	NULL
a	NULL
complex	NULL
puzzle	NULL
with	NULL
few	NULL
casy	NULL
pieces	NULL
.	NULL

Cell	NULL
77:5-7	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Amsterdam	NULL
,	NULL
C.	NULL
Belanger	NULL
,	NULL
and	NULL
R.	NULL
1991	NULL
.	NULL

LEF-1	NULL
,	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
lymphoid-specific	NULL
protein	NULL
with	NULL
an	NULL
HMG	NULL
domain	NULL
,	NULL
regulates	NULL
T-cell	NULL
receptor	NULL
«	NULL
enhancer	NULL
function	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:880-894.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
D.	NULL
Dooijes	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
cloning	NULL
of	NULL
TCF-1	NULL
,	NULL
a	NULL
T	NULL
lymphocyte-specific	NULL
transcription	NULL
factor	NULL
containing	NULL
a	NULL
sequence-specific	NULL
HMG	NULL
box	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:123-132	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.	NULL
C.	NULL
Ho	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
Ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1391-1399	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
W.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
thymus-specific	NULL
member	NULL
of	NULL
the	NULL
HMG	NULL
protein	NULL
family	NULL
regulates	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
C	NULL
alpha	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:656-669	NULL
.	NULL

Winoto	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
novel	NULL
,	NULL
inducible	NULL
and	NULL
T	NULL
cell-specific	NULL
enhancer	NULL
located	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
locus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:729-733	NULL
.	NULL

Wotton	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1994	NULL
.	NULL

Cooperative	NULL
binding	NULL
of	NULL
Ets-1	NULL
and	NULL
core	NULL
binding	NULL
factor	NULL
to	NULL
DNA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:840-850	NULL
.	NULL

Wurster	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
G.	NULL
Siu	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hedrick	NULL
.	NULL

1994	NULL
.	NULL

Elf-1	NULL
binds	NULL
to	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
a	NULL
second	NULL
CD4	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6452-6463	NULL
.	NULL

Yanai	NULL
,	NULL
K.	NULL
,	NULL
Y.	NULL
Nibu	NULL
,	NULL
K.	NULL
Murakami	NULL
,	NULL
and	NULL
A.	NULL
Fukamizu	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
cis-acting	NULL
DNA	NULL
element	NULL
located	NULL
between	NULL
TATA	NULL
box	NULL
and	NULL
transcription	NULL
initiation	NULL
site	NULL
is	NULL
critical	NULL
in	NULL
response	NULL
to	NULL
regulatory	NULL
sequences	NULL
in	NULL
human	NULL
angiotensinogen	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:15981-15986	NULL
.	NULL

Yoshimura	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1990	NULL
.	NULL

Multiple	NULL
cDNA	NULL
clones	NULL
encoding	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
tax-dependent	NULL
enhancer	NULL
of	NULL
HTLV-1	NULL
:	NULL
all	NULL
contain	NULL
a	NULL
leucine	NULL
zipper	NULL
structure	NULL
and	NULL
basic	NULL
amino	NULL
acid	NULL
domain	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:2537-2542	NULL
.	NULL

